{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:14:29Z","timestamp":1793020469237,"version":"4.5.0"},"reference-count":578,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1093\/jac\/dki171","type":"journal-article","created":{"date-parts":[[2005,5,25]],"date-time":"2005-05-25T02:28:18Z","timestamp":1116988098000},"page":"20-51","source":"Crossref","is-referenced-by-count":867,"title":["Efflux-mediated antimicrobial resistance"],"prefix":"10.1093","volume":"56","author":[{"given":"Keith","family":"Poole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,5,24]]},"reference":[{"key":"key\n\t\t\t\t20171012225126_B1","doi-asserted-by":"crossref","unstructured":"Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature1940; 146: 837\u20139.","DOI":"10.1038\/146837a0"},{"key":"key\n\t\t\t\t20171012225126_B2","doi-asserted-by":"crossref","unstructured":"Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med2004; 10: S122\u201329.","DOI":"10.1038\/nm1145"},{"key":"key\n\t\t\t\t20171012225126_B3","doi-asserted-by":"crossref","unstructured":"Howell-Jones RS, Wilson MJ, Hill KE et al. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother2005; 55: 143\u20139.","DOI":"10.1093\/jac\/dkh513"},{"key":"key\n\t\t\t\t20171012225126_B4","doi-asserted-by":"crossref","unstructured":"Finch RG. Antibiotic resistance: a view from the prescriber. Nat Rev Microbiol2004; 2: 989\u201394.","DOI":"10.1038\/nrmicro1049"},{"key":"key\n\t\t\t\t20171012225126_B5","doi-asserted-by":"crossref","unstructured":"Smith SV, Gould IM. Optimization of antibiotic dosing schedules in the light of increasing antibiotic resistance. Expert Rev Anti Infect Ther2004; 2: 227\u201334.","DOI":"10.1586\/14787210.2.2.227"},{"key":"key\n\t\t\t\t20171012225126_B6","doi-asserted-by":"crossref","unstructured":"Pong A, Bradley JS. Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics. Semin Pediatr Infect Dis2004; 15: 21\u20139.","DOI":"10.1053\/j.spid.2004.01.005"},{"key":"key\n\t\t\t\t20171012225126_B7","doi-asserted-by":"crossref","unstructured":"Bronzwaer S, Lonnroth A, Haigh R. The European Community strategy against antimicrobial resistance. Euro Surveill2004; 9: 1\u20133.","DOI":"10.2807\/esm.09.01.00441-en"},{"key":"key\n\t\t\t\t20171012225126_B8","doi-asserted-by":"crossref","unstructured":"Mutnick AH, Rhomberg PR, Sader HS et al. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999\u20132001). J Antimicrob Chemother2004; 53: 290\u20136.","DOI":"10.1093\/jac\/dkh039"},{"key":"key\n\t\t\t\t20171012225126_B9","doi-asserted-by":"crossref","unstructured":"Jain R, Danziger LH. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother2004; 38: 1449\u201359.","DOI":"10.1345\/aph.1D592"},{"key":"key\n\t\t\t\t20171012225126_B10","doi-asserted-by":"crossref","unstructured":"Du B, Long Y, Liu H et al. Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med2002; 28: 1718\u201323.","DOI":"10.1007\/s00134-002-1521-1"},{"key":"key\n\t\t\t\t20171012225126_B11","doi-asserted-by":"crossref","unstructured":"Blot SI, Vandewoude KH, Hoste EA et al. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med2002; 162: 2229\u201335.","DOI":"10.1001\/archinte.162.19.2229"},{"key":"key\n\t\t\t\t20171012225126_B12","doi-asserted-by":"crossref","unstructured":"Kopp BJ, Nix DE, Armstrong EP. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother2004; 38: 1377\u201382.","DOI":"10.1345\/aph.1E028"},{"key":"key\n\t\t\t\t20171012225126_B13","doi-asserted-by":"crossref","unstructured":"DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis2005; 191: 588\u201395.","DOI":"10.1086\/427512"},{"key":"key\n\t\t\t\t20171012225126_B14","doi-asserted-by":"crossref","unstructured":"Overbye KM, Barrett JF. Antibiotics: where did we go wrong? Drug Discov Today2005; 10: 45\u201352.","DOI":"10.1016\/S1359-6446(04)03285-4"},{"key":"key\n\t\t\t\t20171012225126_B15","doi-asserted-by":"crossref","unstructured":"Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis2003; 36: 1433\u20137.","DOI":"10.1086\/375081"},{"key":"key\n\t\t\t\t20171012225126_B16","doi-asserted-by":"crossref","unstructured":"Watters K, O'Dwyer TP, Rowley H. Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences? J Laryngol Otol2004; 118: 694\u20139.","DOI":"10.1258\/0022215042244732"},{"key":"key\n\t\t\t\t20171012225126_B17","doi-asserted-by":"crossref","unstructured":"Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med2001; 29: N114\u2013N120.","DOI":"10.1097\/00003246-200104001-00011"},{"key":"key\n\t\t\t\t20171012225126_B18","doi-asserted-by":"crossref","unstructured":"Engemann JJ, Carmeli Y, Cosgrove SE et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis2003; 36: 592\u20138.","DOI":"10.1086\/367653"},{"key":"key\n\t\t\t\t20171012225126_B19","doi-asserted-by":"crossref","unstructured":"Toubes E, Singh K, Yin D et al. Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin Infect Dis2003; 36: 724\u201330.","DOI":"10.1086\/368081"},{"key":"key\n\t\t\t\t20171012225126_B20","doi-asserted-by":"crossref","unstructured":"Kollef MH. Gram-negative bacterial resistance: evolving patterns and treatment paradigms. Clin Infect Dis2005; 40 Suppl 2: S85\u20138.","DOI":"10.1086\/426187"},{"key":"key\n\t\t\t\t20171012225126_B21","doi-asserted-by":"crossref","unstructured":"Harbarth S, Garbino J, Pugin J et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med2003; 115: 529\u201335.","DOI":"10.1016\/j.amjmed.2003.07.005"},{"key":"key\n\t\t\t\t20171012225126_B22","doi-asserted-by":"crossref","unstructured":"Lodise TP, McKinnon PS, Swiderski L et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis2003; 36: 1418\u201323.","DOI":"10.1086\/375057"},{"key":"key\n\t\t\t\t20171012225126_B23","doi-asserted-by":"crossref","unstructured":"Masterton R, Drusano G, Paterson DL et al. Appropriate antimicrobial treatment in nosocomial infections\u2014the clinical challenges. J Hosp Infect2003; 55 Suppl 1: 1\u201312.","DOI":"10.1016\/S0195-6701(03)00294-9"},{"key":"key\n\t\t\t\t20171012225126_B24","doi-asserted-by":"crossref","unstructured":"Osmon S, Ward S, Fraser VJ et al. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest2004; 125: 607\u201316.","DOI":"10.1378\/chest.125.2.607"},{"key":"key\n\t\t\t\t20171012225126_B25","doi-asserted-by":"crossref","unstructured":"Poole K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol2002; 92 Suppl 1: 55S\u201364S.","DOI":"10.1046\/j.1365-2672.92.5s1.8.x"},{"key":"key\n\t\t\t\t20171012225126_B26","doi-asserted-by":"crossref","unstructured":"Wright GD. Mechanisms of resistance to antibiotics. Curr Opin Chem Biol2003; 7: 563\u20139.","DOI":"10.1016\/j.cbpa.2003.08.004"},{"key":"key\n\t\t\t\t20171012225126_B27","doi-asserted-by":"crossref","unstructured":"McDermott PF, Walker RD, White DG. Antimicrobials: modes of action and mechanisms of resistance. Int J Toxicol2003; 22: 135\u201343.","DOI":"10.1080\/10915810305089"},{"key":"key\n\t\t\t\t20171012225126_B28","doi-asserted-by":"crossref","unstructured":"Hogan D, Kolter R. Why are bacteria refractory to antimicrobials? Curr Opin Microbiol2002; 5: 472.","DOI":"10.1016\/S1369-5274(02)00357-0"},{"key":"key\n\t\t\t\t20171012225126_B29","doi-asserted-by":"crossref","unstructured":"Normark BH, Normark S. Evolution and spread of antibiotic resistance. J Intern Med2002; 252: 91\u2013106.","DOI":"10.1046\/j.1365-2796.2002.01026.x"},{"key":"key\n\t\t\t\t20171012225126_B30","doi-asserted-by":"crossref","unstructured":"Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov2003; 2: 114\u201322.","DOI":"10.1038\/nrd1008"},{"key":"key\n\t\t\t\t20171012225126_B31","doi-asserted-by":"crossref","unstructured":"Gilbert P, Maira-Litran T, McBain AJ et al. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol2002; 46: 202\u201356.","DOI":"10.1016\/S0065-2911(02)46005-5"},{"key":"key\n\t\t\t\t20171012225126_B32","doi-asserted-by":"crossref","unstructured":"Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect2003; 5: 1213\u20139.","DOI":"10.1016\/j.micinf.2003.08.009"},{"key":"key\n\t\t\t\t20171012225126_B33","doi-asserted-by":"crossref","unstructured":"Fux CA, Costerton JW, Stewart PS et al. Survival strategies of infectious biofilms. Trends Microbiol2005; 13: 34\u201340.","DOI":"10.1016\/j.tim.2004.11.010"},{"key":"key\n\t\t\t\t20171012225126_B34","doi-asserted-by":"crossref","unstructured":"Roberts ME, Stewart PS. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells. Microbiology2005; 151: 75\u201380.","DOI":"10.1099\/mic.0.27385-0"},{"key":"key\n\t\t\t\t20171012225126_B35","doi-asserted-by":"crossref","unstructured":"Wattanakaroon W, Stewart PS. Electrical enhancement of Streptococcus gordonii biofilm killing by gentamicin. Arch Oral Biol2000; 45: 167\u201371.","DOI":"10.1016\/S0003-9969(99)00132-6"},{"key":"key\n\t\t\t\t20171012225126_B36","doi-asserted-by":"crossref","unstructured":"Borriello G, Werner E, Roe F et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother2004; 48: 2659\u201364.","DOI":"10.1128\/AAC.48.7.2659-2664.2004"},{"key":"key\n\t\t\t\t20171012225126_B37","doi-asserted-by":"crossref","unstructured":"Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs2004; 64: 159\u2013204.","DOI":"10.2165\/00003495-200464020-00004"},{"key":"key\n\t\t\t\t20171012225126_B38","doi-asserted-by":"crossref","unstructured":"Borges-Walmsley MI, McKeegan KS, Walmsley AR. Structure and function of efflux pumps that confer resistance to drugs. Biochem J2003; 376: 313\u201338.","DOI":"10.1042\/bj20020957"},{"key":"key\n\t\t\t\t20171012225126_B39","doi-asserted-by":"crossref","unstructured":"Chang G. Multidrug resistance ABC transporters. FEBS Lett2003; 555: 102\u20135.","DOI":"10.1016\/S0014-5793(03)01085-8"},{"key":"key\n\t\t\t\t20171012225126_B40","doi-asserted-by":"crossref","unstructured":"Lage H. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents2003; 22: 188\u201399.","DOI":"10.1016\/S0924-8579(03)00203-6"},{"key":"key\n\t\t\t\t20171012225126_B41","unstructured":"Mazurkiewicz P, Driessen AJ, Konings WN. What do proton motive force driven multidrug resistance transporters have in common? Curr Issues Mol Biol2005; 7: 7\u201321."},{"key":"key\n\t\t\t\t20171012225126_B42","doi-asserted-by":"crossref","unstructured":"McMurry LM, Petrucci RE, Jr, Levy SB. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci USA1980; 77: 3974\u20137.","DOI":"10.1073\/pnas.77.7.3974"},{"key":"key\n\t\t\t\t20171012225126_B43","doi-asserted-by":"crossref","unstructured":"Ball PR, Shales SW, Chopra I. Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun1980; 93: 74\u201381.","DOI":"10.1016\/S0006-291X(80)80247-6"},{"key":"key\n\t\t\t\t20171012225126_B44","doi-asserted-by":"crossref","unstructured":"Putman M, van Veen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev2000; 64: 672\u201393.","DOI":"10.1128\/MMBR.64.4.672-693.2000"},{"key":"key\n\t\t\t\t20171012225126_B45","doi-asserted-by":"crossref","unstructured":"Poole K. Multidrug resistance in Gram-negative bacteria. Curr Opin Microbiol2001; 4: 500\u20138.","DOI":"10.1016\/S1369-5274(00)00242-3"},{"key":"key\n\t\t\t\t20171012225126_B46","doi-asserted-by":"crossref","unstructured":"Colmer JA, Fralick JA, Hamood AN. Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae. Mol Microbiol1998; 27: 63\u201372.","DOI":"10.1046\/j.1365-2958.1998.00657.x"},{"key":"key\n\t\t\t\t20171012225126_B47","doi-asserted-by":"crossref","unstructured":"Butaye P, Cloeckaert A, Schwarz S. Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria. Int J Antimicrob Agents2003; 22: 205\u201310.","DOI":"10.1016\/S0924-8579(03)00202-4"},{"key":"key\n\t\t\t\t20171012225126_B48","doi-asserted-by":"crossref","unstructured":"Schwarz S, Kehrenberg C, Doublet B et al. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev2004; 28: 519\u201342.","DOI":"10.1016\/j.femsre.2004.04.001"},{"key":"key\n\t\t\t\t20171012225126_B49","doi-asserted-by":"crossref","unstructured":"Bissonnette L, Champetier S, Buisson JP et al. Characterization of the nonenzymatic chloramphenicol resistance (cmlA) gene of the In4 integron of Tn1696: similarity of the product to transmembrane transport proteins. J Bacteriol1991; 173: 4493\u2013502.","DOI":"10.1128\/jb.173.14.4493-4502.1991"},{"key":"key\n\t\t\t\t20171012225126_B50","doi-asserted-by":"crossref","unstructured":"Guerra B, Soto SM, Arguelles JM et al. Multidrug resistance is mediated by large plasmids carrying a class 1 integron in the emergent Salmonella enterica serotype [4,5,12:i:-]. Antimicrob Agents Chemother2001; 45: 1305\u20138.","DOI":"10.1128\/AAC.45.4.1305-1308.2001"},{"key":"key\n\t\t\t\t20171012225126_B51","doi-asserted-by":"crossref","unstructured":"Naas T, Mikami Y, Imai T et al. Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. J Bacteriol2001; 183: 235\u201349.","DOI":"10.1128\/JB.183.1.235-249.2001"},{"key":"key\n\t\t\t\t20171012225126_B52","doi-asserted-by":"crossref","unstructured":"Chang CY, Chang LL, Chang YH et al. Characterisation of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC. J Med Microbiol2000; 49: 1097\u2013102.","DOI":"10.1099\/0022-1317-49-12-1097"},{"key":"key\n\t\t\t\t20171012225126_B53","doi-asserted-by":"crossref","unstructured":"Partridge SR, Recchia GD, Stokes HW et al. Family of class 1 integrons related to In4 from Tn1696. Antimicrob Agents Chemother2001; 45: 3014\u201320.","DOI":"10.1128\/AAC.45.11.3014-3020.2001"},{"key":"key\n\t\t\t\t20171012225126_B54","doi-asserted-by":"crossref","unstructured":"Doublet B, Lailler R, Meunier D et al. Variant Salmonella genomic island 1 antibiotic resistance gene cluster in Salmonella enterica serovar Albany. Emerg Infect Dis2003; 9: 585\u201391.","DOI":"10.3201\/eid0905.020609"},{"key":"key\n\t\t\t\t20171012225126_B55","doi-asserted-by":"crossref","unstructured":"Doublet B, Butaye P, Imberechts H et al. Salmonella genomic island 1 multidrug resistance gene clusters in Salmonella enterica serovar Agona isolated in Belgium in 1992 to 2002. Antimicrob Agents Chemother2004; 48: 2510\u20137.","DOI":"10.1128\/AAC.48.7.2510-2517.2004"},{"key":"key\n\t\t\t\t20171012225126_B56","doi-asserted-by":"crossref","unstructured":"Doublet B, Weill FX, Fabre L et al. Variant Salmonella genomic island 1 antibiotic resistance gene cluster containing a novel 3\u2032-N-aminoglycoside acetyltransferase gene cassette, aac(3)-Id, in Salmonella enterica serovar Newport. Antimicrob Agents Chemother2004; 48: 3806\u201312.","DOI":"10.1128\/AAC.48.10.3806-3812.2004"},{"key":"key\n\t\t\t\t20171012225126_B57","doi-asserted-by":"crossref","unstructured":"Bischoff KM, White DG, Hume ME et al. The chloramphenicol resistance gene cmlA is disseminated on transferable plasmids that confer multiple-drug resistance in swine Escherichia coli. FEMS Microbiol Lett2005; 243: 285\u201391.","DOI":"10.1016\/j.femsle.2004.12.017"},{"key":"key\n\t\t\t\t20171012225126_B58","doi-asserted-by":"crossref","unstructured":"Gebreyes WA, Thakur S. Multidrug-resistant Salmonella enterica serovar Muenchen from pigs and humans and potential interserovar transfer of antimicrobial resistance. Antimicrob Agents Chemother2005; 49: 503\u201311.","DOI":"10.1128\/AAC.49.2.503-511.2005"},{"key":"key\n\t\t\t\t20171012225126_B59","doi-asserted-by":"crossref","unstructured":"Bischoff KM, White DG, McDermott PF et al. Characterization of chloramphenicol resistance in \u03b2-hemolytic Escherichia coli associated with diarrhea in neonatal swine. J Clin Microbiol2002; 40: 389\u201394.","DOI":"10.1128\/JCM.40.2.389-394.2002"},{"key":"key\n\t\t\t\t20171012225126_B60","doi-asserted-by":"crossref","unstructured":"Boyd D, Cloeckaert A, Chaslus-Dancla E et al. Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother2002; 46: 1714\u201322.","DOI":"10.1128\/AAC.46.6.1714-1722.2002"},{"key":"key\n\t\t\t\t20171012225126_B61","doi-asserted-by":"crossref","unstructured":"Doublet B, Carattoli A, Whichard JM et al. Plasmid-mediated florfenicol and ceftriaxone resistance encoded by the floR and blaCMY-2 genes in Salmonella enterica serovars Typhimurium and Newport isolated in the United States. FEMS Microbiol Lett2004; 233: 301\u20135.","DOI":"10.1111\/j.1574-6968.2004.tb09496.x"},{"key":"key\n\t\t\t\t20171012225126_B62","doi-asserted-by":"crossref","unstructured":"Randall LP, Cooles SW, Osborn MK et al. Antibiotic resistance genes, integrons and multiple antibiotic resistance in thirty-five serotypes of Salmonella enterica isolated from humans and animals in the UK. J Antimicrob Chemother2004; 53: 208\u201316.","DOI":"10.1093\/jac\/dkh070"},{"key":"key\n\t\t\t\t20171012225126_B63","doi-asserted-by":"crossref","unstructured":"Iwanaga M, Toma C, Miyazato T et al. Antibiotic resistance conferred by a class I integron and SXT constin in Vibrio cholerae O1 strains isolated in Laos. Antimicrob Agents Chemother2004; 48: 2364\u20139.","DOI":"10.1128\/AAC.48.7.2364-2369.2004"},{"key":"key\n\t\t\t\t20171012225126_B64","doi-asserted-by":"crossref","unstructured":"White DG, Hudson C, Maurer JJ et al. Characterization of chloramphenicol and florfenicol resistance in Escherichia coli associated with bovine diarrhea. J Clin Microbiol2000; 38: 4593\u20138.","DOI":"10.1128\/JCM.38.12.4593-4598.2000"},{"key":"key\n\t\t\t\t20171012225126_B65","doi-asserted-by":"crossref","unstructured":"Du X, Xia C, Shen J et al. Characterization of florfenicol resistance among calf pathogenic Escherichia coli. FEMS Microbiol Lett2004; 236: 183\u20139.","DOI":"10.1111\/j.1574-6968.2004.tb09645.x"},{"key":"key\n\t\t\t\t20171012225126_B66","doi-asserted-by":"crossref","unstructured":"Sanchez S, McCrackin Stevenson MA, Hudson CR et al. Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J Clin Microbiol2002; 40: 3586\u201395.","DOI":"10.1128\/JCM.40.10.3586-3595.2002"},{"key":"key\n\t\t\t\t20171012225126_B67","doi-asserted-by":"crossref","unstructured":"Keyes K, Hudson C, Maurer JJ et al. Detection of florfenicol resistance genes in Escherichia coli isolated from sick chickens. Antimicrob Agents Chemother2000; 44: 421\u20134.","DOI":"10.1128\/AAC.44.2.421-424.2000"},{"key":"key\n\t\t\t\t20171012225126_B68","doi-asserted-by":"crossref","unstructured":"Singer RS, Patterson SK, Meier AE et al. Relationship between phenotypic and genotypic florfenicol resistance in Escherichia coli. Antimicrob Agents Chemother2004; 48: 4047\u20139.","DOI":"10.1128\/AAC.48.10.4047-4049.2004"},{"key":"key\n\t\t\t\t20171012225126_B69","doi-asserted-by":"crossref","unstructured":"Cabrera R, Ruiz J, Marco F et al. Mechanism of resistance to several antimicrobial agents in Salmonella clinical isolates causing traveler's diarrhea. Antimicrob Agents Chemother2004; 48: 3934\u20139.","DOI":"10.1128\/AAC.48.10.3934-3939.2004"},{"key":"key\n\t\t\t\t20171012225126_B70","doi-asserted-by":"crossref","unstructured":"Kehrenberg C, Schwarz S. fexA, a novel Staphylococcus lentus gene encoding resistance to florfenicol and chloramphenicol. Antimicrob Agents Chemother2004; 48: 615\u20138.","DOI":"10.1128\/AAC.48.2.615-618.2004"},{"key":"key\n\t\t\t\t20171012225126_B71","doi-asserted-by":"crossref","unstructured":"Kehrenberg C, Schwarz S. Florfenicol-chloramphenicol exporter gene fexA is part of the novel transposon Tn558. Antimicrob Agents Chemother2005; 49: 813\u20135.","DOI":"10.1128\/AAC.49.2.813-815.2005"},{"key":"key\n\t\t\t\t20171012225126_B72","doi-asserted-by":"crossref","unstructured":"George AM, Hall RM. Efflux of chloramphenicol by the CmlA1 protein. FEMS Microbiol Lett2002; 209: 209\u201313.","DOI":"10.1111\/j.1574-6968.2002.tb11133.x"},{"key":"key\n\t\t\t\t20171012225126_B73","doi-asserted-by":"crossref","unstructured":"Desomer J, Vereecke D, Crespi M et al. The plasmid-encoded chloramphenicol-resistance protein of Rhodococcus fascians is homologous to the transmembrane tetracycline efflux proteins. Mol Microbiol1992; 6: 2377\u201385.","DOI":"10.1111\/j.1365-2958.1992.tb01412.x"},{"key":"key\n\t\t\t\t20171012225126_B74","doi-asserted-by":"crossref","unstructured":"Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect2004; 10: 12\u201326.","DOI":"10.1111\/j.1469-0691.2004.00763.x"},{"key":"key\n\t\t\t\t20171012225126_B75","doi-asserted-by":"crossref","unstructured":"Baucheron S, Tyler S, Boyd D et al. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104. Antimicrob Agents Chemother2004; 48: 3729\u201335.","DOI":"10.1128\/AAC.48.10.3729-3735.2004"},{"key":"key\n\t\t\t\t20171012225126_B76","doi-asserted-by":"crossref","unstructured":"Hasdemir UO, Chevalier J, Nordmann P et al. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol2004; 42: 2701\u20136.","DOI":"10.1128\/JCM.42.6.2701-2706.2004"},{"key":"key\n\t\t\t\t20171012225126_B77","doi-asserted-by":"crossref","unstructured":"Chau SL, Chu YW, Houang ET. Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3. Antimicrob Agents Chemother2004; 48: 4054\u20135.","DOI":"10.1128\/AAC.48.10.4054-4055.2004"},{"key":"key\n\t\t\t\t20171012225126_B78","doi-asserted-by":"crossref","unstructured":"Jalal S, Wretlind G, Gotoh N et al. Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa. APMIS1999; 107: 1109\u201316.","DOI":"10.1111\/j.1699-0463.1999.tb01516.x"},{"key":"key\n\t\t\t\t20171012225126_B79","doi-asserted-by":"crossref","unstructured":"Kohler T, Van Delden C, Curty LK et al. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol2001; 183: 5213\u201322.","DOI":"10.1128\/JB.183.18.5213-5222.2001"},{"key":"key\n\t\t\t\t20171012225126_B80","doi-asserted-by":"crossref","unstructured":"Sobel ML, Poole K, Neshat S. Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa. J Bacteriol2005; 187: 1246\u201353.","DOI":"10.1128\/JB.187.4.1246-1253.2005"},{"key":"key\n\t\t\t\t20171012225126_B81","doi-asserted-by":"crossref","unstructured":"Rajyaguru JM, Muszynski MJ. Association of resistance to trimethoprim\/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia. J Antimicrob Chemother1997; 40: 803\u20139.","DOI":"10.1093\/jac\/40.6.803"},{"key":"key\n\t\t\t\t20171012225126_B82","doi-asserted-by":"crossref","unstructured":"Nair BM, Cheung K, Jr, Griffith A et al. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest2004; 113: 464\u201373.","DOI":"10.1172\/JCI200419710"},{"key":"key\n\t\t\t\t20171012225126_B83","doi-asserted-by":"crossref","unstructured":"Burns JL, Wadsworth CD, Barry JJ et al. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother1996; 40: 307\u201313.","DOI":"10.1128\/AAC.40.2.307"},{"key":"key\n\t\t\t\t20171012225126_B84","doi-asserted-by":"crossref","unstructured":"Hansen LH, Johannesen E, Burmolle M et al. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother2004; 48: 3332\u20137.","DOI":"10.1128\/AAC.48.9.3332-3337.2004"},{"key":"key\n\t\t\t\t20171012225126_B85","doi-asserted-by":"crossref","unstructured":"Poelarends G, Mazurkiewicz P, Konings W. Multidrug transporters and antibiotic resistance in Lactococcus lactis. Biochim Biophys Acta2002; 1555: 1.","DOI":"10.1016\/S0005-2728(02)00246-3"},{"key":"key\n\t\t\t\t20171012225126_B86","doi-asserted-by":"crossref","unstructured":"Olliver A, Valle M, Chaslus-Dancla E et al. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob Agents Chemother2005; 49: 289\u2013301.","DOI":"10.1128\/AAC.49.1.289-301.2005"},{"key":"key\n\t\t\t\t20171012225126_B87","doi-asserted-by":"crossref","unstructured":"Roberts MC. Tetracycline therapy: update. Clin Infect Dis2003; 36: 462\u20137.","DOI":"10.1086\/367622"},{"key":"key\n\t\t\t\t20171012225126_B88","unstructured":"Bartlett JG. 2004 Pocket Book of Infectious Disease Therapy, 12 edn. Baltimore: Lippincott Williams & Wilkins, 2004."},{"key":"key\n\t\t\t\t20171012225126_B89","doi-asserted-by":"crossref","unstructured":"Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 2005; 245: 195\u2013203.","DOI":"10.1016\/j.femsle.2005.02.034"},{"key":"key\n\t\t\t\t20171012225126_B90","doi-asserted-by":"crossref","unstructured":"Maynard C, Bekal S, Sanschagrin F et al. Heterogeneity among virulence and antimicrobial resistance gene profiles of extraintestinal Escherichia coli isolates of animal and human origin. J Clin Microbiol2004; 42: 5444\u201352.","DOI":"10.1128\/JCM.42.12.5444-5452.2004"},{"key":"key\n\t\t\t\t20171012225126_B91","doi-asserted-by":"crossref","unstructured":"Butler MJ, Friend EJ, Hunter IS et al. Molecular cloning of resistance genes and architecture of a linked gene cluster involved in biosynthesis of oxytetracycline by Streptomyces rimosus. Mol Gen Genet1989; 215: 231\u20138.","DOI":"10.1007\/BF00339722"},{"key":"key\n\t\t\t\t20171012225126_B92","doi-asserted-by":"crossref","unstructured":"Reynes JP, Calmels T, Drocourt D et al. Cloning, expression in Escherichia coli and nucleotide sequence of a tetracycline-resistance gene from Streptomyces rimosus. J Gen Microbiol1988; 134: 585\u201398.","DOI":"10.1099\/00221287-134-3-585"},{"key":"key\n\t\t\t\t20171012225126_B93","doi-asserted-by":"crossref","unstructured":"Dairi T, Aisaka K, Katsumata R et al. A self-defense gene homologous to tetracycline effluxing gene essential for antibiotic production in Streptomyces aureofaciens. Biosci Biotechnol Biochem1995; 59: 1835\u201341.","DOI":"10.1271\/bbb.59.1835"},{"key":"key\n\t\t\t\t20171012225126_B94","doi-asserted-by":"crossref","unstructured":"Truong-Bolduc QC, Dunman PM, Strahilevitz J et al. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol2005; 187: 2395\u2013405.","DOI":"10.1128\/JB.187.7.2395-2405.2005"},{"key":"key\n\t\t\t\t20171012225126_B95","doi-asserted-by":"crossref","unstructured":"Viveiros M, Leandro C, Amaral L. Mycobacterial efflux pumps and chemotherapeutic implications. Int J Antimicrob Agents2003; 22: 274\u20138.","DOI":"10.1016\/S0924-8579(03)00208-5"},{"key":"key\n\t\t\t\t20171012225126_B96","doi-asserted-by":"crossref","unstructured":"Agers\u00f8 Y, Guardabassi L. Identification of Tet 39, a novel class of tetracycline resistance determinant in Acinetobacter spp. of environmental and clinical origin. J Antimicrob Chemother2005; 55: 566\u20139.","DOI":"10.1093\/jac\/dki051"},{"key":"key\n\t\t\t\t20171012225126_B97","doi-asserted-by":"crossref","unstructured":"Poyart C, Jardy L, Quesne G et al. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother2003; 47: 794\u20137.","DOI":"10.1128\/AAC.47.2.794-797.2003"},{"key":"key\n\t\t\t\t20171012225126_B98","doi-asserted-by":"crossref","unstructured":"Lancaster H, Ready D, Mullany P et al. Prevalence and identification of tetracycline-resistant oral bacteria in children not receiving antibiotic therapy. FEMS Microbiol Lett2003; 228: 99\u2013104.","DOI":"10.1016\/S0378-1097(03)00740-7"},{"key":"key\n\t\t\t\t20171012225126_B99","doi-asserted-by":"crossref","unstructured":"Duarte RS, Bellei BC, Miranda OP et al. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agents Chemother2005; 49: 97\u2013103.","DOI":"10.1128\/AAC.49.1.97-103.2005"},{"key":"key\n\t\t\t\t20171012225126_B100","doi-asserted-by":"crossref","unstructured":"Nielsen HU, Hammerum AM, Ekelund K et al. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist2004; 10: 231\u20138.","DOI":"10.1089\/mdr.2004.10.231"},{"key":"key\n\t\t\t\t20171012225126_B101","doi-asserted-by":"crossref","unstructured":"Tian Y, Aarestrup FM, Lu CP. Characterization of Streptococcus suis serotype 7 isolates from diseased pigs in Denmark. Vet Microbiol2004; 103: 55\u201362.","DOI":"10.1016\/j.vetmic.2004.07.009"},{"key":"key\n\t\t\t\t20171012225126_B102","doi-asserted-by":"crossref","unstructured":"Brenciani A, Ojo KK, Monachetti A et al. Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. J Antimicrob Chemother2004; 54: 991\u20138.","DOI":"10.1093\/jac\/dkh481"},{"key":"key\n\t\t\t\t20171012225126_B103","doi-asserted-by":"crossref","unstructured":"Matsumoto M, Sakae K, Ohta M et al. Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11. Int J Antimicrob Agents2005; 25: 142\u20137.","DOI":"10.1016\/j.ijantimicag.2004.09.014"},{"key":"key\n\t\t\t\t20171012225126_B104","doi-asserted-by":"crossref","unstructured":"Rodriguez-Avial I, Rodriguez-Avial C, Culebras E et al. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin\/dalfopristin and linezolid. Int J Antimicrob Agents2003; 21: 536\u201341.","DOI":"10.1016\/S0924-8579(03)00062-1"},{"key":"key\n\t\t\t\t20171012225126_B105","doi-asserted-by":"crossref","unstructured":"Petersen A, Dalsgaard A. Species composition and antimicrobial resistance genes of Enterococcus spp, isolated from integrated and traditional fish farms in Thailand. Environ Microbiol2003; 5: 395\u2013402.","DOI":"10.1046\/j.1462-2920.2003.00430.x"},{"key":"key\n\t\t\t\t20171012225126_B106","doi-asserted-by":"crossref","unstructured":"Huys G, D'Haene K, Collard JM et al. Prevalence and molecular characterization of tetracycline resistance in Enterococcus isolates from food. Appl Environ Microbiol2004; 70: 1555\u201362.","DOI":"10.1128\/AEM.70.3.1555-1562.2004"},{"key":"key\n\t\t\t\t20171012225126_B107","doi-asserted-by":"crossref","unstructured":"Ng LK, Martin I, Alfa M et al. Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes2001; 15: 209\u201315.","DOI":"10.1006\/mcpr.2001.0363"},{"key":"key\n\t\t\t\t20171012225126_B108","doi-asserted-by":"crossref","unstructured":"Strommenger B, Kettlitz C, Werner G et al. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol2003; 41: 4089\u201394.","DOI":"10.1128\/JCM.41.9.4089-4094.2003"},{"key":"key\n\t\t\t\t20171012225126_B109","unstructured":"Sekiguchi J, Fujino T, Saruta K et al. Prevalence of erythromycin-, tetracycline-, and aminoglycoside-resistance genes in methicillin-resistant Staphylococcus aureus in hospitals in Tokyo and Kumamoto. Jpn J Infect Dis2004; 57: 74\u20137."},{"key":"key\n\t\t\t\t20171012225126_B110","doi-asserted-by":"crossref","unstructured":"Aarestrup FM, Jensen LB. Trends in antimicrobial susceptibility in relation to antimicrobial usage and presence of resistance genes in Staphylococcus hyicus isolated from exudative epidermitis in pigs. Vet Microbiol2002; 89: 83\u201394.","DOI":"10.1016\/S0378-1135(02)00177-3"},{"key":"key\n\t\t\t\t20171012225126_B111","doi-asserted-by":"crossref","unstructured":"Aarestrup FM, Agers LY, Ahrens P et al. Antimicrobial susceptibility and presence of resistance genes in staphylococci from poultry. Vet Microbiol2000; 74: 353\u201364.","DOI":"10.1016\/S0378-1135(00)00197-8"},{"key":"key\n\t\t\t\t20171012225126_B112","doi-asserted-by":"crossref","unstructured":"Wilcks A, Andersen SR, Licht TR. Characterization of transferable tetracycline resistance genes in Enterococcus faecalis isolated from raw food. FEMS Microbiol Lett2005; 243: 15\u20139.","DOI":"10.1016\/j.femsle.2004.11.028"},{"key":"key\n\t\t\t\t20171012225126_B113","doi-asserted-by":"crossref","unstructured":"Aarestrup FM, Lertworapreecha M, Evans MC et al. Antimicrobial susceptibility and occurrence of resistance genes among Salmonella enterica serovar Weltevreden from different countries. J Antimicrob Chemother2003; 52: 715\u20138.","DOI":"10.1093\/jac\/dkg426"},{"key":"key\n\t\t\t\t20171012225126_B114","doi-asserted-by":"crossref","unstructured":"Frech G, Schwarz S. Molecular analysis of tetracycline resistance in Salmonella enterica subsp. enterica serovars Typhimurium, Enteritidis, Dublin, Choleraesuis, Hadar and Saintpaul: construction and application of specific gene probes. J Appl Microbiol2000; 89: 633\u201341.","DOI":"10.1046\/j.1365-2672.2000.01160.x"},{"key":"key\n\t\t\t\t20171012225126_B115","doi-asserted-by":"crossref","unstructured":"Poppe C, Ziebell K, Martin L et al. Diversity in antimicrobial resistance and other characteristics among Salmonella typhimurium DT104 isolates. Microb Drug Resist2002; 8: 107\u201322.","DOI":"10.1089\/107662902760190653"},{"key":"key\n\t\t\t\t20171012225126_B116","doi-asserted-by":"crossref","unstructured":"Pasquali F, De Cesare A, Ricci A et al. Phage types, ribotypes and tetracycline resistance genes of Salmonella enterica subsp. enterica serovar Typhimurium strains isolated from different origins in Italy. Vet Microbiol2004; 103: 71\u20136.","DOI":"10.1016\/j.vetmic.2004.07.007"},{"key":"key\n\t\t\t\t20171012225126_B117","doi-asserted-by":"crossref","unstructured":"Hartman AB, Essiet II, Isenbarger DW et al. Epidemiology of tetracycline resistance determinants in Shigella spp. and enteroinvasive Escherichia coli: characterization and dissemination of tet(A)-1. J Clin Microbiol2003; 41: 1023\u201332.","DOI":"10.1128\/JCM.41.3.1023-1032.2003"},{"key":"key\n\t\t\t\t20171012225126_B118","doi-asserted-by":"crossref","unstructured":"Toro CS, Farfan M, Contreras I et al. Genetic analysis of antibiotic-resistance determinants in multidrug-resistant Shigella strains isolated from Chilean children. Epidemiol Infect2005; 133: 81\u20136.","DOI":"10.1017\/S0950268804003048"},{"key":"key\n\t\t\t\t20171012225126_B119","doi-asserted-by":"crossref","unstructured":"Guerra B, Junker E, Schroeter A et al. Phenotypic and genotypic characterization of antimicrobial resistance in German Escherichia coli isolates from cattle, swine and poultry. J Antimicrob Chemother2003; 52: 489\u201392.","DOI":"10.1093\/jac\/dkg362"},{"key":"key\n\t\t\t\t20171012225126_B120","doi-asserted-by":"crossref","unstructured":"Sengelov G, Halling-Sorensen B, Aarestrup FM. Susceptibility of Escherichia coli and Enterococcus faecium isolated from pigs and broiler chickens to tetracycline degradation products and distribution of tetracycline resistance determinants in E. coli from food animals. Vet Microbiol2003; 95: 91\u2013101.","DOI":"10.1016\/S0378-1135(03)00123-8"},{"key":"key\n\t\t\t\t20171012225126_B121","doi-asserted-by":"crossref","unstructured":"Guardabassi L, Dijkshoorn L, Collard JM et al. Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains. J Med Microbiol2000; 49: 929\u201336.","DOI":"10.1099\/0022-1317-49-10-929"},{"key":"key\n\t\t\t\t20171012225126_B122","doi-asserted-by":"crossref","unstructured":"Dugan J, Rockey DD, Jones L et al. Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene. Antimicrob Agents Chemother2004; 48: 3989\u201395.","DOI":"10.1128\/AAC.48.10.3989-3995.2004"},{"key":"key\n\t\t\t\t20171012225126_B123","doi-asserted-by":"crossref","unstructured":"Wu JY, Kim JJ, Reddy R et al. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother2005; 49: 578\u201383.","DOI":"10.1128\/AAC.49.2.578-583.2005"},{"key":"key\n\t\t\t\t20171012225126_B124","doi-asserted-by":"crossref","unstructured":"Gibreel A, Tracz DM, Nonaka L et al. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob Agents Chemother2004; 48: 3442\u201350.","DOI":"10.1128\/AAC.48.9.3442-3450.2004"},{"key":"key\n\t\t\t\t20171012225126_B125","doi-asserted-by":"crossref","unstructured":"Turner A, Gough KR, Leeming JP. Molecular epidemiology of tetM genes in Neisseria gonorrhoeae. Sex Transm Infect1999; 75: 60\u20136.","DOI":"10.1136\/sti.75.1.60"},{"key":"key\n\t\t\t\t20171012225126_B126","doi-asserted-by":"crossref","unstructured":"Marquez CM, Dillon JA, Rodriguez V et al. Detection of a novel Tet M determinant in tetracycline-resistant Neisseria gonorrhoeae from Uruguay, 1996\u20131999. Sex Transm Dis2002; 29: 792\u20137.","DOI":"10.1097\/00007435-200212000-00010"},{"key":"key\n\t\t\t\t20171012225126_B127","doi-asserted-by":"crossref","unstructured":"Furushita M, Shiba T, Maeda T et al. Similarity of tetracycline resistance genes isolated from fish farm bacteria to those from clinical isolates. Appl Environ Microbiol2003; 69: 5336\u201342.","DOI":"10.1128\/AEM.69.9.5336-5342.2003"},{"key":"key\n\t\t\t\t20171012225126_B128","doi-asserted-by":"crossref","unstructured":"Cousin S, Jr, Roberts MC, Whittington WL. Insertion of a thymine (+T) in the 13 base pair inverted repeat of the Neisseria gonorrhoeae mtr promoter region and antibiotic susceptibility. Int J Antimicrob Agents2004; 23: 418\u20139.","DOI":"10.1016\/j.ijantimicag.2004.01.001"},{"key":"key\n\t\t\t\t20171012225126_B129","doi-asserted-by":"crossref","unstructured":"De Rossi E, Arrigo P, Bellinzoni M et al. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol Med2002; 8: 714\u201324.","DOI":"10.1007\/BF03402035"},{"key":"key\n\t\t\t\t20171012225126_B130","doi-asserted-by":"crossref","unstructured":"Ainsa JA, Blokpoel MC, Otal I et al. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol1998; 180: 5836\u201343.","DOI":"10.1128\/JB.180.22.5836-5843.1998"},{"key":"key\n\t\t\t\t20171012225126_B131","doi-asserted-by":"crossref","unstructured":"Silva PE, Bigi F, de La Paz SM et al. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob Agents Chemother2001; 45: 800\u20134.","DOI":"10.1128\/AAC.45.3.800-804.2001"},{"key":"key\n\t\t\t\t20171012225126_B132","doi-asserted-by":"crossref","unstructured":"Hamzehpour MM, Pechere J-C, Plesiat P et al. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Antimicrob Agents Chemother1995; 39: 2392\u20136.","DOI":"10.1128\/AAC.39.11.2392"},{"key":"key\n\t\t\t\t20171012225126_B133","doi-asserted-by":"crossref","unstructured":"Alonso A, Campanario E, Martinez JL. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology1999; 145: 2857\u201362.","DOI":"10.1099\/00221287-145-10-2857"},{"key":"key\n\t\t\t\t20171012225126_B134","doi-asserted-by":"crossref","unstructured":"Alonso A, Martinez JL. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother2000; 44: 3079\u201386.","DOI":"10.1128\/AAC.44.11.3079-3086.2000"},{"key":"key\n\t\t\t\t20171012225126_B135","doi-asserted-by":"crossref","unstructured":"Alonso A, Martinez JL. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother1997; 41: 1140\u20132.","DOI":"10.1128\/AAC.41.5.1140"},{"key":"key\n\t\t\t\t20171012225126_B136","doi-asserted-by":"crossref","unstructured":"Zhang L, Li X-Z, Poole K. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother2000; 44: 287\u201393.","DOI":"10.1128\/AAC.44.2.287-293.2000"},{"key":"key\n\t\t\t\t20171012225126_B137","doi-asserted-by":"crossref","unstructured":"Masuda N, Sakagawa E, Ohya S et al. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother2000; 44: 2242\u20136.","DOI":"10.1128\/AAC.44.9.2242-2246.2000"},{"key":"key\n\t\t\t\t20171012225126_B138","doi-asserted-by":"crossref","unstructured":"Goldman RC, Scaglione F. The macrolide\u2013bacterium interaction and its biological basis. Curr Drug Targets Infect Disord2004; 4: 241\u201360.","DOI":"10.2174\/1568005043340812"},{"key":"key\n\t\t\t\t20171012225126_B139","doi-asserted-by":"crossref","unstructured":"Zhanel GG, Dueck M, Hoban DJ et al. Review of macrolides and ketolides: focus on respiratory tract infections. Drugs2001; 61: 443\u201398.","DOI":"10.2165\/00003495-200161040-00003"},{"key":"key\n\t\t\t\t20171012225126_B140","doi-asserted-by":"crossref","unstructured":"Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis2002; 34: 482\u201392.","DOI":"10.1086\/324626"},{"key":"key\n\t\t\t\t20171012225126_B141","doi-asserted-by":"crossref","unstructured":"Zuckerman JM. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am2004; 18: 621\u201349.","DOI":"10.1016\/j.idc.2004.04.010"},{"key":"key\n\t\t\t\t20171012225126_B142","doi-asserted-by":"crossref","unstructured":"Spizek J, Rezanka T. Lincomycin, clindamycin and their applications. Appl Microbiol Biotechnol2004; 64: 455\u201364.","DOI":"10.1007\/s00253-003-1545-7"},{"key":"key\n\t\t\t\t20171012225126_B143","doi-asserted-by":"crossref","unstructured":"Blondeau JM, Sanche SE. Quinupristin\/dalfopristin. Expert Opin Pharmacother2002; 3: 1341\u201364.","DOI":"10.1517\/14656566.3.9.1341"},{"key":"key\n\t\t\t\t20171012225126_B144","doi-asserted-by":"crossref","unstructured":"Bermudez LE, Yamazaki Y. Effects of macrolides and ketolides on mycobacterial infections. Curr Pharm Des2004; 10: 3221\u20138.","DOI":"10.2174\/1381612043383241"},{"key":"key\n\t\t\t\t20171012225126_B145","doi-asserted-by":"crossref","unstructured":"Roberts MC. Distribution of macrolide, lincosamide, streptogramin, ketolide and oxazolidinone (MLSKO) resistance genes in Gram-negative bacteria. Curr Drug Targets Infect Disord2004; 4: 207\u201315.","DOI":"10.2174\/1568005043340678"},{"key":"key\n\t\t\t\t20171012225126_B146","doi-asserted-by":"crossref","unstructured":"Pozzi G, Iannelli F, Oggioni MR et al. Genetic elements carrying macrolide efflux genes in streptococci. Curr Drug Targets Infect Disord2004; 4: 203\u20136.","DOI":"10.2174\/1568005043340641"},{"key":"key\n\t\t\t\t20171012225126_B147","doi-asserted-by":"crossref","unstructured":"Roberts MC, Sutcliffe J, Courvalin P et al. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother1999; 43: 2823\u201330.","DOI":"10.1128\/AAC.43.12.2823"},{"key":"key\n\t\t\t\t20171012225126_B147A","doi-asserted-by":"crossref","unstructured":"Klaassen CH, Mouton JW. Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E). Antimicrob Agents Chemother2005; 49: 1271\u20138.","DOI":"10.1128\/AAC.49.4.1271-1278.2005"},{"key":"key\n\t\t\t\t20171012225126_B148","doi-asserted-by":"crossref","unstructured":"Giovanetti E, Brenciani A, Vecchi M et al. Prophage association of mefA elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes. J Antimicrob Chemother2005; 55: 445\u201351.","DOI":"10.1093\/jac\/dki049"},{"key":"key\n\t\t\t\t20171012225126_B149","doi-asserted-by":"crossref","unstructured":"Daly MM, Doktor S, Flamm R et al. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates. J Clin Microbiol2004; 42: 3570\u20134.","DOI":"10.1128\/JCM.42.8.3570-3574.2004"},{"key":"key\n\t\t\t\t20171012225126_B150","doi-asserted-by":"crossref","unstructured":"Montanari MP, Tili E, Cochetti I et al. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy. Microb Drug Resist2004; 10: 209\u201317.","DOI":"10.1089\/mdr.2004.10.209"},{"key":"key\n\t\t\t\t20171012225126_B151","doi-asserted-by":"crossref","unstructured":"Hotomi M, Yamanaka N, Billal DS et al. Genotyping of Streptococcus pneumoniae and Haemophilus influenzae isolated from paired middle ear fluid and nasopharynx by pulsed-field gel electrophoresis. ORL J Otorhinolaryngol Relat Spec2004; 66: 233\u201340.","DOI":"10.1159\/000081119"},{"key":"key\n\t\t\t\t20171012225126_B152","doi-asserted-by":"crossref","unstructured":"Hsueh PR, Teng LJ, Lee LN et al. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979\u20131998) but not in Streptococcus pneumoniae (1985\u20131999) in Taiwan. Microb Drug Resist2002; 8: 27\u201333.","DOI":"10.1089\/10766290252913728"},{"key":"key\n\t\t\t\t20171012225126_B153","doi-asserted-by":"crossref","unstructured":"Farrell DJ, Morrissey I, Bakker S et al. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance. J Clin Microbiol2004; 42: 764\u20138.","DOI":"10.1128\/JCM.42.2.764-768.2004"},{"key":"key\n\t\t\t\t20171012225126_B154","doi-asserted-by":"crossref","unstructured":"Brown SD, Farrell DJ, Morrissey I. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000\u20132001 PROTEKT US Study. J Clin Microbiol2004; 42: 4980\u20137.","DOI":"10.1128\/JCM.42.11.4980-4987.2004"},{"key":"key\n\t\t\t\t20171012225126_B155","doi-asserted-by":"crossref","unstructured":"Jacobs MR, Johnson CE. Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis J2003; 22: S131\u20138.","DOI":"10.1097\/00006454-200308001-00004"},{"key":"key\n\t\t\t\t20171012225126_B156","doi-asserted-by":"crossref","unstructured":"Fotopoulou N, Tassios PT, Beste DV et al. A common clone of erythromycin-resistant Streptococcus pneumoniae in Greece and the UK. Clin Microbiol Infect2003; 9: 924\u20139.","DOI":"10.1046\/j.1469-0691.2003.00689.x"},{"key":"key\n\t\t\t\t20171012225126_B157","doi-asserted-by":"crossref","unstructured":"Monaco M, Camilli R, D'Ambrosio F et al. Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. J Antimicrob Chemother2005; 55: 256\u20139.","DOI":"10.1093\/jac\/dkh551"},{"key":"key\n\t\t\t\t20171012225126_B158","doi-asserted-by":"crossref","unstructured":"Wierzbowski AK, Swedlo D, Boyd D et al. Molecular epidemiology and prevalence of macrolide efflux genes mefA and mefE in Streptococcus pneumoniae obtained in Canada from 1997 to 2002. Antimicrob Agents Chemother2005; 49: 1257\u201361.","DOI":"10.1128\/AAC.49.3.1257-1261.2005"},{"key":"key\n\t\t\t\t20171012225126_B159","doi-asserted-by":"crossref","unstructured":"Bonofiglio L, Ojeda MI, de Mier C et al. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital. Int J Antimicrob Agents2005; 25: 260\u20133.","DOI":"10.1016\/j.ijantimicag.2004.10.011"},{"key":"key\n\t\t\t\t20171012225126_B160","doi-asserted-by":"crossref","unstructured":"Hotomi M, Billal DS, Shimada J et al. Increase of macrolide-resistant Streptococcus pneumoniae expressing mefE or ermB gene in the nasopharynx among children with otitis media. Laryngoscope2005; 115: 317\u201320.","DOI":"10.1097\/01.mlg.0000154740.48314.d5"},{"key":"key\n\t\t\t\t20171012225126_B161","doi-asserted-by":"crossref","unstructured":"Beekmann SE, Heilmann KP, Richter SS et al. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002\u20132003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents2005; 25: 148\u201356.","DOI":"10.1016\/j.ijantimicag.2004.09.016"},{"key":"key\n\t\t\t\t20171012225126_B162","doi-asserted-by":"crossref","unstructured":"Ardanuy C, Tubau F, Linares J et al. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes. Antimicrob Agents Chemother2005; 49: 827\u20139.","DOI":"10.1128\/AAC.49.2.827-829.2005"},{"key":"key\n\t\t\t\t20171012225126_B163","doi-asserted-by":"crossref","unstructured":"Desjardins M, Delgaty KL, Ramotar K et al. Prevalence and mechanisms of erythromycin resistance in group A and group B streptococcus: implications for reporting susceptibility results. J Clin Microbiol2004; 42: 5620\u20133.","DOI":"10.1128\/JCM.42.12.5620-5623.2004"},{"key":"key\n\t\t\t\t20171012225126_B164","doi-asserted-by":"crossref","unstructured":"Ko WC, Yan JJ, Lee NY et al. Polyclonal spread of erythromycin-resistant Streptococcus agalactiae in southern Taiwan. Microb Drug Resist2004; 10: 306\u201312.","DOI":"10.1089\/mdr.2004.10.306"},{"key":"key\n\t\t\t\t20171012225126_B165","doi-asserted-by":"crossref","unstructured":"Cerda Zolezzi P, Laplana LM, Calvo CR et al. Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae. Antimicrob Agents Chemother2004; 48: 3462\u20137.","DOI":"10.1128\/AAC.48.9.3462-3467.2004"},{"key":"key\n\t\t\t\t20171012225126_B166","doi-asserted-by":"crossref","unstructured":"Bozdogan B, Appelbaum PC. Macrolide resistance in streptococci and Haemophilus influenzae. Clin Lab Med2004; 24: 455\u201375.","DOI":"10.1016\/j.cll.2004.03.006"},{"key":"key\n\t\t\t\t20171012225126_B167","doi-asserted-by":"crossref","unstructured":"Edelstein PH. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes. Clin Infect Dis2004; 38 Suppl 4: S322\u20137.","DOI":"10.1086\/382687"},{"key":"key\n\t\t\t\t20171012225126_B168","doi-asserted-by":"crossref","unstructured":"Cousin SL, Jr, Whittington WL, Roberts MC. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. J Antimicrob Chemother2003; 51: 131\u20133.","DOI":"10.1093\/jac\/dkg040"},{"key":"key\n\t\t\t\t20171012225126_B169","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang GR, Shelby A et al. A newly discovered Bacteroides conjugative transposon, CTnGERM1, contains genes also found in gram-positive bacteria. Appl Environ Microbiol2003; 69: 4595\u2013603.","DOI":"10.1128\/AEM.69.8.4595-4603.2003"},{"key":"key\n\t\t\t\t20171012225126_B170","doi-asserted-by":"crossref","unstructured":"Ojo KK, Ulep C, Van Kirk N et al. The mef(A) gene predominates among seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob Agents Chemother2004; 48: 3451\u20136.","DOI":"10.1128\/AAC.48.9.3451-3456.2004"},{"key":"key\n\t\t\t\t20171012225126_B171","doi-asserted-by":"crossref","unstructured":"Cousin S, Jr, Whittington WL, Roberts MC. Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987. Antimicrob Agents Chemother2003; 47: 3877\u201380.","DOI":"10.1128\/AAC.47.12.3877-3880.2003"},{"key":"key\n\t\t\t\t20171012225126_B172","doi-asserted-by":"crossref","unstructured":"Lebel S, Bouttier S, Lambert T. The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis. FEMS Microbiol Lett2004; 238: 93\u2013100.","DOI":"10.1016\/j.femsle.2004.07.022"},{"key":"key\n\t\t\t\t20171012225126_B173","doi-asserted-by":"crossref","unstructured":"Reynolds E, Ross JI, Cove JH. Msr(A) and related macrolide\/streptogramin resistance determinants: incomplete transporters? Int J Antimicrob Agents2003; 22: 228\u201336.","DOI":"10.1016\/S0924-8579(03)00218-8"},{"key":"key\n\t\t\t\t20171012225126_B174","doi-asserted-by":"crossref","unstructured":"Lina G, Quaglia A, Reverdy ME et al. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother1999; 43: 1062\u20136.","DOI":"10.1128\/AAC.43.5.1062"},{"key":"key\n\t\t\t\t20171012225126_B175","doi-asserted-by":"crossref","unstructured":"Schmitz FJ, Sadurski R, Kray A et al. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother2000; 45: 891\u20134.","DOI":"10.1093\/jac\/45.6.891"},{"key":"key\n\t\t\t\t20171012225126_B176","doi-asserted-by":"crossref","unstructured":"Haroche J, Morvan A, Davi M et al. Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals. J Clin Microbiol2003; 41: 586\u201391.","DOI":"10.1128\/JCM.41.2.586-591.2003"},{"key":"key\n\t\t\t\t20171012225126_B177","doi-asserted-by":"crossref","unstructured":"Haroche J, Allignet J, Buchrieser C et al. Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds. Antimicrob Agents Chemother2000; 44: 2271\u20135.","DOI":"10.1128\/AAC.44.9.2271-2275.2000"},{"key":"key\n\t\t\t\t20171012225126_B178","doi-asserted-by":"crossref","unstructured":"Allignet J, El Solh N. Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds. Gene1997; 202: 133\u20138.","DOI":"10.1016\/S0378-1119(97)00464-2"},{"key":"key\n\t\t\t\t20171012225126_B179","doi-asserted-by":"crossref","unstructured":"Haroche J, Allignet J, El Solh N. Tn5406, a new staphylococcal transposon conferring resistance to streptogramin a and related compounds including dalfopristin. Antimicrob Agents Chemother2002; 46: 2337\u201343.","DOI":"10.1128\/AAC.46.8.2337-2343.2002"},{"key":"key\n\t\t\t\t20171012225126_B180","doi-asserted-by":"crossref","unstructured":"Portillo A, Ruiz-Larrea F, Zarazaga M et al. Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother2000; 44: 967\u201371.","DOI":"10.1128\/AAC.44.4.967-971.2000"},{"key":"key\n\t\t\t\t20171012225126_B181","doi-asserted-by":"crossref","unstructured":"Singh KV, Malathum K, Murray BE. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob Agents Chemother2001; 45: 263\u20136.","DOI":"10.1128\/AAC.45.1.263-266.2001"},{"key":"key\n\t\t\t\t20171012225126_B182","doi-asserted-by":"crossref","unstructured":"Hayes JR, Wagner DD, English LL et al. Distribution of streptogramin resistance determinants among Enterococcus faecium from a poultry production environment of the USA. J Antimicrob Chemother2005; 55: 123\u20136.","DOI":"10.1093\/jac\/dkh491"},{"key":"key\n\t\t\t\t20171012225126_B183","doi-asserted-by":"crossref","unstructured":"Chesneau O, Ligeret H, Hosan-Aghaie N et al. Molecular analysis of resistance to streptogramin a compounds conferred by the Vga proteins of staphylococci. Antimicrob Agents Chemother2005; 49: 973\u201380.","DOI":"10.1128\/AAC.49.3.973-980.2005"},{"key":"key\n\t\t\t\t20171012225126_B184","doi-asserted-by":"crossref","unstructured":"Banks DJ, Porcella SF, Barbian KD et al. Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J Infect Dis2003; 188: 1898\u2013908.","DOI":"10.1086\/379897"},{"key":"key\n\t\t\t\t20171012225126_B185","doi-asserted-by":"crossref","unstructured":"Singh KV, Weinstock GM, Murray BE. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin\u2013dalfopristin. Antimicrob Agents Chemother2002; 46: 1845\u201350.","DOI":"10.1128\/AAC.46.6.1845-1850.2002"},{"key":"key\n\t\t\t\t20171012225126_B186","doi-asserted-by":"crossref","unstructured":"Dina J, Malbruny B, Leclercq R. Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A. Antimicrob Agents Chemother2003; 47: 2307\u20139.","DOI":"10.1128\/AAC.47.7.2307-2309.2003"},{"key":"key\n\t\t\t\t20171012225126_B187","doi-asserted-by":"crossref","unstructured":"Kehrenberg C, Ojo KK, Schwarz S. Nucleotide sequence and organization of the multiresistance plasmid pSCFS1 from Staphylococcus sciuri. J Antimicrob Chemother2004; 54: 936\u20139.","DOI":"10.1093\/jac\/dkh457"},{"key":"key\n\t\t\t\t20171012225126_B188","doi-asserted-by":"crossref","unstructured":"Giovanetti E, Brenciani A, Burioni R et al. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. Antimicrob Agents Chemother2002; 46: 3750\u20135.","DOI":"10.1128\/AAC.46.12.3750-3755.2002"},{"key":"key\n\t\t\t\t20171012225126_B189","doi-asserted-by":"crossref","unstructured":"Murata M, Ohno S, Kumano M et al. Multidrug resistant phenotype of Bacillus subtilis spontaneous mutants isolated in the presence of puromycin and lincomycin. Can J Microbiol2003; 49: 71\u20137.","DOI":"10.1139\/w03-014"},{"key":"key\n\t\t\t\t20171012225126_B190","doi-asserted-by":"crossref","unstructured":"Kumano M, Fujita M, Nakamura K et al. Lincomycin resistance mutations in two regions immediately downstream of the \u221210 region of lmr promoter cause overexpression of a putative multidrug efflux pump in Bacillus subtilis mutants. Antimicrob Agents Chemother2003; 47: 432\u20135.","DOI":"10.1128\/AAC.47.1.432-435.2003"},{"key":"key\n\t\t\t\t20171012225126_B191","doi-asserted-by":"crossref","unstructured":"Kim HJ, Kim Y, Lee MS et al. Gene lmrB of Corynebacterium glutamicum confers efflux-mediated resistance to lincomycin. Mol Cells2001; 12: 112\u20136.","DOI":"10.1016\/S1016-8478(23)17069-5"},{"key":"key\n\t\t\t\t20171012225126_B192","doi-asserted-by":"crossref","unstructured":"Huang J, O'Toole PW, Shen W et al. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob Agents Chemother2004; 48: 909\u201317.","DOI":"10.1128\/AAC.48.3.909-917.2004"},{"key":"key\n\t\t\t\t20171012225126_B193","doi-asserted-by":"crossref","unstructured":"Szczepanowski R, Krahn I, Linke B et al. Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system. Microbiology2004; 150: 3613\u201330.","DOI":"10.1099\/mic.0.27317-0"},{"key":"key\n\t\t\t\t20171012225126_B194","doi-asserted-by":"crossref","unstructured":"Poole K. Outer membranes and efflux: the path to multidrug resistance in gram-negative bacteria. Curr Pharm Biotechnol2002; 3: 77\u201398.","DOI":"10.2174\/1389201023378454"},{"key":"key\n\t\t\t\t20171012225126_B195","doi-asserted-by":"crossref","unstructured":"Chollet R, Chevalier J, Bryskier A et al. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob Agents Chemother2004; 48: 3621\u20134.","DOI":"10.1128\/AAC.48.9.3621-3624.2004"},{"key":"key\n\t\t\t\t20171012225126_B196","doi-asserted-by":"crossref","unstructured":"Jellen-Ritter AS, Kern WV. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother2001; 45: 1467\u201372.","DOI":"10.1128\/AAC.45.5.1467-1472.2001"},{"key":"key\n\t\t\t\t20171012225126_B197","doi-asserted-by":"crossref","unstructured":"Zarantonelli L, Borthagaray G, Lee EH et al. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother1999; 43: 2468\u201372.","DOI":"10.1128\/AAC.43.10.2468"},{"key":"key\n\t\t\t\t20171012225126_B198","doi-asserted-by":"crossref","unstructured":"Zarantonelli L, Borthagaray G, Lee EH et al. Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. J Antimicrob Chemother2001; 47: 651\u20134.","DOI":"10.1093\/jac\/47.5.651"},{"key":"key\n\t\t\t\t20171012225126_B199","doi-asserted-by":"crossref","unstructured":"Peric M, Bozdogan B, Jacobs MR et al. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother2003; 47: 1017\u201322.","DOI":"10.1128\/AAC.47.3.1017-1022.2003"},{"key":"key\n\t\t\t\t20171012225126_B200","doi-asserted-by":"crossref","unstructured":"Peric M, Bozdogan B, Galderisi C et al. Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S. J Antimicrob Chemother2004; 54: 393\u2013400.","DOI":"10.1093\/jac\/dkh364"},{"key":"key\n\t\t\t\t20171012225126_B201","doi-asserted-by":"crossref","unstructured":"Tauch A, Schluter A, Bischoff N et al. The 79, 370-bp conjugative plasmid pB4 consists of an IncP-1\u03b2 backbone loaded with a chromate resistance transposon, the strA-strB streptomycin resistance gene pair, the oxacillinase gene bla(NPS-1), and a tripartite antibiotic efflux system of the resistance-nodulation-division family. Mol Genet Genomics2003; 268: 570\u201384.","DOI":"10.1007\/s00438-002-0785-z"},{"key":"key\n\t\t\t\t20171012225126_B202","doi-asserted-by":"crossref","unstructured":"Mamelli L, Amoros JP, Pages JM et al. A phenylalanine-arginine \u03b2-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int J Antimicrob Agents2003; 22: 237\u201341.","DOI":"10.1016\/S0924-8579(03)00199-7"},{"key":"key\n\t\t\t\t20171012225126_B203","doi-asserted-by":"crossref","unstructured":"Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother2002; 46: 2124\u201331.","DOI":"10.1128\/AAC.46.7.2124-2131.2002"},{"key":"key\n\t\t\t\t20171012225126_B204","doi-asserted-by":"crossref","unstructured":"Ball P. Quinolone generations: natural history or natural selection? J Antimicrob Chemother2000; 46 Suppl T1: 17\u201324.","DOI":"10.1093\/oxfordjournals.jac.a020889"},{"key":"key\n\t\t\t\t20171012225126_B205","doi-asserted-by":"crossref","unstructured":"Jacobs MR. Fluoroquinolones as chemotherapeutics against mycobacterial infections. Curr Pharm Des2004; 10: 3213\u201320.","DOI":"10.2174\/1381612043383296"},{"key":"key\n\t\t\t\t20171012225126_B206","doi-asserted-by":"crossref","unstructured":"Fish DN. Levofloxacin: update and perspectives on one of the original \u2018respiratory quinolones\u2019. Expert Rev Anti Infect Ther2003; 1: 371\u201387.","DOI":"10.1586\/14787210.1.3.371"},{"key":"key\n\t\t\t\t20171012225126_B207","doi-asserted-by":"crossref","unstructured":"O'Donnell JA, Gelone SP. The newer fluoroquinolones. Infect Dis Clin North Am2004; 18: 691\u2013716.","DOI":"10.1016\/j.idc.2004.04.011"},{"key":"key\n\t\t\t\t20171012225126_B208","doi-asserted-by":"crossref","unstructured":"Schito AM, Schito GC. Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa. J Chemother2004; 16 Suppl 2: 3\u20137.","DOI":"10.1080\/1120009X.2004.11782365"},{"key":"key\n\t\t\t\t20171012225126_B209","doi-asserted-by":"crossref","unstructured":"Poole K. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria. Antimicrob Agents Chemother2000; 44: 2595\u20139.","DOI":"10.1128\/AAC.44.10.2595-2599.2000"},{"key":"key\n\t\t\t\t20171012225126_B210","doi-asserted-by":"crossref","unstructured":"Poole K. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob Agents Chemother2000; 44: 2233\u201341.","DOI":"10.1128\/AAC.44.9.2233-2241.2000"},{"key":"key\n\t\t\t\t20171012225126_B211","doi-asserted-by":"crossref","unstructured":"Schmitz FJ, Higgins PG, Mayer S et al. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur J Clin Microbiol Infect Dis2002; 21: 647\u201359.","DOI":"10.1007\/s10096-002-0788-z"},{"key":"key\n\t\t\t\t20171012225126_B212","doi-asserted-by":"crossref","unstructured":"Kaatz GW, Moudgal VV, Seo SM. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J Antimicrob Chemother2002; 50: 833\u20138.","DOI":"10.1093\/jac\/dkf224"},{"key":"key\n\t\t\t\t20171012225126_B213","doi-asserted-by":"crossref","unstructured":"Brenwald NP, Appelbaum P, Davies T et al. Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Clin Microbiol Infect2003; 9: 140\u20133.","DOI":"10.1046\/j.1469-0691.2003.00482.x"},{"key":"key\n\t\t\t\t20171012225126_B214","doi-asserted-by":"crossref","unstructured":"Kaatz GW, Seo SM. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob Agents Chemother1995; 39: 2650\u20135.","DOI":"10.1128\/AAC.39.12.2650"},{"key":"key\n\t\t\t\t20171012225126_B215","doi-asserted-by":"crossref","unstructured":"Kaatz GW, Seo SM, Ruble CA. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother1993; 37: 1086\u201394.","DOI":"10.1128\/AAC.37.5.1086"},{"key":"key\n\t\t\t\t20171012225126_B216","doi-asserted-by":"crossref","unstructured":"Tanaka M, Wang T, Onodera Y et al. Mechanism of quinolone resistance in Staphylococcus aureus. J Infect Chemother2000; 6: 131\u20139.","DOI":"10.1007\/s101560070010"},{"key":"key\n\t\t\t\t20171012225126_B217","doi-asserted-by":"crossref","unstructured":"Oizumi N, Kawabata S, Hirao M et al. Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus. J Infect Chemother2001; 7: 191\u20134.","DOI":"10.1007\/s101560100034"},{"key":"key\n\t\t\t\t20171012225126_B218","doi-asserted-by":"crossref","unstructured":"Kaatz GW, Seo SM, Foster TJ. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration. Antimicrob Agents Chemother1999; 43: 2222\u20134.","DOI":"10.1128\/AAC.43.9.2222"},{"key":"key\n\t\t\t\t20171012225126_B219","doi-asserted-by":"crossref","unstructured":"Ng EYW, Truckis M, Hooper DC. Quinolone resistance mediated by norA: physiological characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob Agents Chemother1994; 38: 1345\u201355.","DOI":"10.1128\/AAC.38.6.1345"},{"key":"key\n\t\t\t\t20171012225126_B220","doi-asserted-by":"crossref","unstructured":"Fournier B, Truong-Bolduc QC, Zhang X et al. A mutation in the 5\u2032 untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J Bacteriol2001; 183: 2367\u201371.","DOI":"10.1128\/JB.183.7.2367-2371.2001"},{"key":"key\n\t\t\t\t20171012225126_B221","doi-asserted-by":"crossref","unstructured":"Piddock LJ, Jin YF, Webber MA et al. Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus. Antimicrob Agents Chemother2002; 46: 2276\u20138.","DOI":"10.1128\/AAC.46.7.2276-2278.2002"},{"key":"key\n\t\t\t\t20171012225126_B222","doi-asserted-by":"crossref","unstructured":"Truong-Bolduc QC, Zhang X, Hooper DC. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J Bacteriol2003; 185: 3127\u201338.","DOI":"10.1128\/JB.185.10.3127-3138.2003"},{"key":"key\n\t\t\t\t20171012225126_B223","doi-asserted-by":"crossref","unstructured":"Roychoudhury S, Twinem TL, Makin KM et al. Staphylococcus aureus mutants isolated via exposure to nonfluorinated quinolones: detection of known and unique mutations. Antimicrob Agents Chemother2001; 45: 3422\u20136.","DOI":"10.1128\/AAC.45.12.3422-3426.2001"},{"key":"key\n\t\t\t\t20171012225126_B224","doi-asserted-by":"crossref","unstructured":"Daporta MT, Munoz Bellido JL, Guirao GY et al. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae. Int J Antimicrob Agents2004; 24: 185\u20137.","DOI":"10.1016\/j.ijantimicag.2004.01.012"},{"key":"key\n\t\t\t\t20171012225126_B225","doi-asserted-by":"crossref","unstructured":"Mayer S, Boos M, Kohrer K et al. In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin. Eur J Clin Microbiol Infect Dis2001; 20: 288\u201391.","DOI":"10.1007\/PL00011267"},{"key":"key\n\t\t\t\t20171012225126_B226","doi-asserted-by":"crossref","unstructured":"Johnson AP, Sheppard CL, Harnett SJ et al. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. J Antimicrob Chemother2003; 52: 953\u201360.","DOI":"10.1093\/jac\/dkg469"},{"key":"key\n\t\t\t\t20171012225126_B227","doi-asserted-by":"crossref","unstructured":"Pletz MW, McGee L, Jorgensen J et al. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother2004; 48: 3491\u20137.","DOI":"10.1128\/AAC.48.9.3491-3497.2004"},{"key":"key\n\t\t\t\t20171012225126_B228","doi-asserted-by":"crossref","unstructured":"De La Campa AG, Balsalobre L, Ardanuy C et al. Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain. Emerg Infect Dis2004; 10: 1751\u20139.","DOI":"10.3201\/eid1010.040382"},{"key":"key\n\t\t\t\t20171012225126_B229","doi-asserted-by":"crossref","unstructured":"Azoulay-Dupuis E, Bedos JP, Mohler J et al. Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model. Antimicrob Agents Chemother2005; 49: 1046\u201354.","DOI":"10.1128\/AAC.49.3.1046-1054.2005"},{"key":"key\n\t\t\t\t20171012225126_B230","doi-asserted-by":"crossref","unstructured":"Ferrandiz MJ, Oteo J, Aracil B et al. Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. Antimicrob Agents Chemother1999; 43: 2520\u20133.","DOI":"10.1128\/AAC.43.10.2520"},{"key":"key\n\t\t\t\t20171012225126_B231","doi-asserted-by":"crossref","unstructured":"Guerin F, Varon E, Hoi AB et al. Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci. Antimicrob Agents Chemother2000; 44: 2197\u2013200.","DOI":"10.1128\/AAC.44.8.2197-2200.2000"},{"key":"key\n\t\t\t\t20171012225126_B232","doi-asserted-by":"crossref","unstructured":"Beyer R, Pestova E, Millichap JJ et al. A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux. Antimicrob Agents Chemother2000; 44: 798\u2013801.","DOI":"10.1128\/AAC.44.3.798-801.2000"},{"key":"key\n\t\t\t\t20171012225126_B233","doi-asserted-by":"crossref","unstructured":"Godreuil S, Galimand M, Gerbaud G et al. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob Agents Chemother2003; 47: 704\u20138.","DOI":"10.1128\/AAC.47.2.704-708.2003"},{"key":"key\n\t\t\t\t20171012225126_B234","doi-asserted-by":"crossref","unstructured":"Lynch C, Courvalin P, Nikaido H. Active efflux of antimicrobial agents in wild-type strains of Enterococci. Antimicrob Agents Chemother1997; 41: 869\u201371.","DOI":"10.1128\/AAC.41.4.869"},{"key":"key\n\t\t\t\t20171012225126_B235","doi-asserted-by":"crossref","unstructured":"Jonas BM, Murray BE, Weinstock GM. Characterization of EmeA, a NorA homolog and multidrug resistance efflux pump, in Enterococcus faecalis. Antimicrob Agents Chemother2001; 45: 3574\u20139.","DOI":"10.1128\/AAC.45.12.3574-3579.2001"},{"key":"key\n\t\t\t\t20171012225126_B235A","doi-asserted-by":"crossref","unstructured":"Lee EW, Chen J, Huda MN et al. Functional cloning and expression of emeA, and characterization of EmeA, a multidrug efflux pump from Enterococcus faecalis. Biol Pharm Bull2003; 26: 266\u201370.","DOI":"10.1248\/bpb.26.266"},{"key":"key\n\t\t\t\t20171012225126_B236","doi-asserted-by":"crossref","unstructured":"Grohs P, Podglajen I, Gutmann L. Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations. Antimicrob Agents Chemother2004; 48: 3024\u20137.","DOI":"10.1128\/AAC.48.8.3024-3027.2004"},{"key":"key\n\t\t\t\t20171012225126_B237","doi-asserted-by":"crossref","unstructured":"Bast DJ, Athamna A, Duncan CL et al. Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance. J Antimicrob Chemother2004; 54: 90\u20134.","DOI":"10.1093\/jac\/dkh294"},{"key":"key\n\t\t\t\t20171012225126_B238","doi-asserted-by":"crossref","unstructured":"Read TD, Salzberg SL, Pop M et al. Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science2002; 296: 2028\u201333.","DOI":"10.1126\/science.1071837"},{"key":"key\n\t\t\t\t20171012225126_B239","doi-asserted-by":"crossref","unstructured":"Konings WN, Poelarends GJ. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein. IUBMB Life2002; 53: 213\u20138.","DOI":"10.1080\/15216540212646"},{"key":"key\n\t\t\t\t20171012225126_B240","doi-asserted-by":"crossref","unstructured":"Raherison S, Gonzalez P, Renaudin H et al. Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis. Antimicrob Agents Chemother2005; 49: 421\u20134.","DOI":"10.1128\/AAC.49.1.421-424.2005"},{"key":"key\n\t\t\t\t20171012225126_B241","doi-asserted-by":"crossref","unstructured":"Raherison S, Gonzalez P, Renaudin H et al. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis. Antimicrob Agents Chemother2002; 46: 672\u20139.","DOI":"10.1128\/AAC.46.3.672-679.2002"},{"key":"key\n\t\t\t\t20171012225126_B242","doi-asserted-by":"crossref","unstructured":"Li XZ, Zhang L, Nikaido H. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother2004; 48: 2415\u201323.","DOI":"10.1128\/AAC.48.7.2415-2423.2004"},{"key":"key\n\t\t\t\t20171012225126_B243","doi-asserted-by":"crossref","unstructured":"Pasca MR, Guglierame P, Arcesi F et al. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob Agents Chemother2004; 48: 3175\u20138.","DOI":"10.1128\/AAC.48.8.3175-3178.2004"},{"key":"key\n\t\t\t\t20171012225126_B244","doi-asserted-by":"crossref","unstructured":"Banerjee SK, Bhatt K, Rana S et al. Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis. Biochem Biophys Res Commun1996; 226: 362\u20138.","DOI":"10.1006\/bbrc.1996.1362"},{"key":"key\n\t\t\t\t20171012225126_B245","doi-asserted-by":"crossref","unstructured":"Siddiqi N, Das R, Pathak N et al. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a Tap-like efflux pump. Infection2004; 32: 109\u201311.","DOI":"10.1007\/s15010-004-3097-x"},{"key":"key\n\t\t\t\t20171012225126_B246","doi-asserted-by":"crossref","unstructured":"Rella M, Haas D. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of \u03b2-lactam antibiotics: mapping of chromosomal genes. Antimicrob Agents Chemother1982; 22: 242\u20139.","DOI":"10.1128\/AAC.22.2.242"},{"key":"key\n\t\t\t\t20171012225126_B247","doi-asserted-by":"crossref","unstructured":"Hirai K, Suzue S, Irikura T et al. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother1987; 31: 582\u20136.","DOI":"10.1128\/AAC.31.4.582"},{"key":"key\n\t\t\t\t20171012225126_B248","doi-asserted-by":"crossref","unstructured":"Celesk RA, Robillard RA. Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother1989; 33: 1921\u20136.","DOI":"10.1128\/AAC.33.11.1921"},{"key":"key\n\t\t\t\t20171012225126_B249","doi-asserted-by":"crossref","unstructured":"Chamberland S, Bayer AS, Schollaardt T et al. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother1989; 33: 624\u201334.","DOI":"10.1128\/AAC.33.5.624"},{"key":"key\n\t\t\t\t20171012225126_B250","doi-asserted-by":"crossref","unstructured":"Poole K. Efflux pumps. In Ramos J-L, ed. Pseudomonas, Vol. I. Genomics, Life Style and Molecular Architecture. New York: Kluwer Academic\/Plenum Publishers, 2004; 635\u201374.","DOI":"10.1007\/978-1-4419-9086-0_21"},{"key":"key\n\t\t\t\t20171012225126_B251","unstructured":"Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. In Paulsen IT, Lewis K, eds. Microbial Multidrug Efflux. UK: Horizon Scientific Press, 2003; 273\u201398."},{"key":"key\n\t\t\t\t20171012225126_B252","doi-asserted-by":"crossref","unstructured":"Poole K, Srikumar R. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr Top Med Chem2001; 1: 59\u201371.","DOI":"10.2174\/1568026013395605"},{"key":"key\n\t\t\t\t20171012225126_B253","doi-asserted-by":"crossref","unstructured":"Dupont P, Hocquet D, Jeannot K et al. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa. J Antimicrob Chemother2005; 55: 518\u201322.","DOI":"10.1093\/jac\/dki030"},{"key":"key\n\t\t\t\t20171012225126_B254","doi-asserted-by":"crossref","unstructured":"Kriengkauykiat J, Porter E, Lomovskaya O et al. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother2005; 49: 565\u201370.","DOI":"10.1128\/AAC.49.2.565-570.2005"},{"key":"key\n\t\t\t\t20171012225126_B255","doi-asserted-by":"crossref","unstructured":"Giraud E, Blanc G, Bouju-Albert A et al. Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis. J Med Microbiol2004; 53: 895\u2013901.","DOI":"10.1099\/jmm.0.45579-0"},{"key":"key\n\t\t\t\t20171012225126_B256","doi-asserted-by":"crossref","unstructured":"Pumbwe L, Randall LP, Woodward MJ et al. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J Antimicrob Chemother2004; 54: 341\u20137.","DOI":"10.1093\/jac\/dkh331"},{"key":"key\n\t\t\t\t20171012225126_B257","doi-asserted-by":"crossref","unstructured":"Zhang Q, Lin J, Pereira S. Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness. Anim Health Res Rev2003; 4: 63\u201371.","DOI":"10.1079\/AHR200356"},{"key":"key\n\t\t\t\t20171012225126_B258","doi-asserted-by":"crossref","unstructured":"Linde HJ, Notka F, Irtenkauf C et al. Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae. J Antimicrob Chemother2002; 49: 625\u201330.","DOI":"10.1093\/jac\/49.4.625"},{"key":"key\n\t\t\t\t20171012225126_B259","doi-asserted-by":"crossref","unstructured":"Mazzariol A, Tokue Y, Kanegawa TM et al. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother2000; 44: 3441\u20133.","DOI":"10.1128\/AAC.44.12.3441-3443.2000"},{"key":"key\n\t\t\t\t20171012225126_B260","doi-asserted-by":"crossref","unstructured":"Wang H, Dzink-Fox JL, Chen M et al. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother2001; 45: 1515\u201321.","DOI":"10.1128\/AAC.45.5.1515-1521.2001"},{"key":"key\n\t\t\t\t20171012225126_B261","doi-asserted-by":"crossref","unstructured":"Gruteke P, Goessens W, Van Gils J et al. Patterns of resistance associated with integrons, the extended-spectrum \u03b2-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J Clin Microbiol2003; 41: 1161\u20136.","DOI":"10.1128\/JCM.41.3.1161-1166.2003"},{"key":"key\n\t\t\t\t20171012225126_B262","doi-asserted-by":"crossref","unstructured":"Wagenlehner FM, Heisig P, Irtenkauf C et al. Clinically significant borderline resistance of sequential clinical isolates of Klebsiella pneumoniae. Int J Antimicrob Agents2003; 22: 367\u201373.","DOI":"10.1016\/S0924-8579(03)00126-2"},{"key":"key\n\t\t\t\t20171012225126_B263","doi-asserted-by":"crossref","unstructured":"Mazzariol A, Zuliani J, Cornaglia G et al. AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob Agents Chemother2002; 46: 3984\u20136.","DOI":"10.1128\/AAC.46.12.3984-3986.2002"},{"key":"key\n\t\t\t\t20171012225126_B264","doi-asserted-by":"crossref","unstructured":"del Mar TM, Vila J, Ruiz J et al. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii. Int J Antimicrob Agents2000; 14: 157\u201360.","DOI":"10.1016\/S0924-8579(00)00117-5"},{"key":"key\n\t\t\t\t20171012225126_B265","doi-asserted-by":"crossref","unstructured":"Oh H, Stenhoff J, Jalal S et al. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist2003; 9: 323\u20138.","DOI":"10.1089\/107662903322762743"},{"key":"key\n\t\t\t\t20171012225126_B266","doi-asserted-by":"crossref","unstructured":"Teresa TM, Martin JL, Navia M et al. Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections. Vet Microbiol2003; 94: 295\u2013301.","DOI":"10.1016\/S0378-1135(03)00129-9"},{"key":"key\n\t\t\t\t20171012225126_B267","doi-asserted-by":"crossref","unstructured":"Higgins PG, Fluit AC, Milatovic D et al. Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents2003; 21: 409\u201313.","DOI":"10.1016\/S0924-8579(03)00009-8"},{"key":"key\n\t\t\t\t20171012225126_B268","doi-asserted-by":"crossref","unstructured":"Le Thomas I, Couetdic G, Clermont O et al. In vivo selection of a target\/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy. J Antimicrob Chemother2001; 48: 553\u20135.","DOI":"10.1093\/jac\/48.4.553"},{"key":"key\n\t\t\t\t20171012225126_B269","doi-asserted-by":"crossref","unstructured":"Llanes C, Hocquet D, Vogne C et al. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother2004; 48: 1797\u2013802.","DOI":"10.1128\/AAC.48.5.1797-1802.2004"},{"key":"key\n\t\t\t\t20171012225126_B270","doi-asserted-by":"crossref","unstructured":"Escribano I, Rodriguez JC, Cebrian L et al. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int J Antimicrob Agents2004; 24: 428\u201332.","DOI":"10.1016\/j.ijantimicag.2004.05.004"},{"key":"key\n\t\t\t\t20171012225126_B271","doi-asserted-by":"crossref","unstructured":"Olliver A, Valle M, Chaslus-Dancla E et al. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol Lett2004; 238: 267\u201372.","DOI":"10.1111\/j.1574-6968.2004.tb09766.x"},{"key":"key\n\t\t\t\t20171012225126_B272","doi-asserted-by":"crossref","unstructured":"Baucheron S, Chaslus-Dancla E, Cloeckaert A. Role of tolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J Antimicrob Chemother2004; 53: 657\u20139.","DOI":"10.1093\/jac\/dkh122"},{"key":"key\n\t\t\t\t20171012225126_B273","doi-asserted-by":"crossref","unstructured":"Casin I, Breuil J, Darchis JP et al. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans. Emerg Infect Dis2003; 9: 1455\u20137.","DOI":"10.3201\/eid0911.030317"},{"key":"key\n\t\t\t\t20171012225126_B274","doi-asserted-by":"crossref","unstructured":"Soto SM, Ruiz J, Mendoza MC et al. In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance. Int J Antimicrob Agents2003; 22: 537\u201340.","DOI":"10.1016\/S0924-8579(03)00241-3"},{"key":"key\n\t\t\t\t20171012225126_B275","doi-asserted-by":"crossref","unstructured":"Cebrian L, Rodriguez JC, Escribano I et al. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms. Chemotherapy (Basel)2005; 51: 40\u20133.","DOI":"10.1159\/000084417"},{"key":"key\n\t\t\t\t20171012225126_B276","doi-asserted-by":"crossref","unstructured":"Kumar A, Worobec EA. Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump. J Antimicrob Chemother2002; 50: 593\u20136.","DOI":"10.1093\/jac\/dkf147"},{"key":"key\n\t\t\t\t20171012225126_B276A","doi-asserted-by":"crossref","unstructured":"Kumar A, Worobec EA. Cloning, sequencing, and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob Agents Chemother2005; 49: 1495\u2013501.","DOI":"10.1128\/AAC.49.4.1495-1501.2005"},{"key":"key\n\t\t\t\t20171012225126_B277","doi-asserted-by":"crossref","unstructured":"Chang LL, Chen HF, Chang CY et al. Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother2004; 53: 518\u201321.","DOI":"10.1093\/jac\/dkh094"},{"key":"key\n\t\t\t\t20171012225126_B278","doi-asserted-by":"crossref","unstructured":"Ricci V, Peterson ML, Rotschafer JC et al. Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrob Agents Chemother2004; 48: 1344\u20136.","DOI":"10.1128\/AAC.48.4.1344-1346.2004"},{"key":"key\n\t\t\t\t20171012225126_B279","doi-asserted-by":"crossref","unstructured":"Ricci V, Piddock L. Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. J Antimicrob Chemother2003; 52: 605\u20139.","DOI":"10.1093\/jac\/dkg418"},{"key":"key\n\t\t\t\t20171012225126_B280","doi-asserted-by":"crossref","unstructured":"Dewi BE, Akira S, Hayashi H et al. High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae. Sex Transm Dis2004; 31: 353\u20139.","DOI":"10.1097\/00007435-200406000-00007"},{"key":"key\n\t\t\t\t20171012225126_B281","doi-asserted-by":"crossref","unstructured":"Capilla S, Ruiz J, Goni P et al. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates. J Antimicrob Chemother2004; 53: 1068\u201371.","DOI":"10.1093\/jac\/dkh225"},{"key":"key\n\t\t\t\t20171012225126_B282","doi-asserted-by":"crossref","unstructured":"Ribera A, Ruiz J, Jiminez de Anta MT et al. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother2002; 49: 697\u20138.","DOI":"10.1093\/jac\/49.4.697"},{"key":"key\n\t\t\t\t20171012225126_B283","doi-asserted-by":"crossref","unstructured":"Higgins PG, Wisplinghoff H, Stefanik D et al. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J Antimicrob Chemother2004; 54: 821\u20133.","DOI":"10.1093\/jac\/dkh427"},{"key":"key\n\t\t\t\t20171012225126_B284","doi-asserted-by":"crossref","unstructured":"Kern WV, Oethinger M, Jellen-Ritter AS et al. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother2000; 44: 814\u201320.","DOI":"10.1128\/AAC.44.4.814-820.2000"},{"key":"key\n\t\t\t\t20171012225126_B285","doi-asserted-by":"crossref","unstructured":"Alekshun MN, Levy SB. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol1999; 7: 410\u20133.","DOI":"10.1016\/S0966-842X(99)01589-9"},{"key":"key\n\t\t\t\t20171012225126_B286","doi-asserted-by":"crossref","unstructured":"Maneewannakul K, Levy SB. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother1996; 40: 1695\u20138.","DOI":"10.1128\/AAC.40.7.1695"},{"key":"key\n\t\t\t\t20171012225126_B287","doi-asserted-by":"crossref","unstructured":"Golding SS, Matthews KR. Intrinsic mechanism decreases susceptibility of Escherichia coli O157:H7 to multiple antibiotics. J Food Prot2004; 67: 34\u20139.","DOI":"10.4315\/0362-028X-67.1.34"},{"key":"key\n\t\t\t\t20171012225126_B288","doi-asserted-by":"crossref","unstructured":"Yaron S, White DG, Matthews KR. Characterization of an Escherichia coli O157:H7 marR mutant. Int J Food Microbiol2003; 85: 281\u201391.","DOI":"10.1016\/S0168-1605(02)00547-0"},{"key":"key\n\t\t\t\t20171012225126_B289","doi-asserted-by":"crossref","unstructured":"Ba BB, Feghali H, Arpin C et al. Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic\u2013pharmacodynamic model. Antimicrob Agents Chemother2004; 48: 946\u201353.","DOI":"10.1128\/AAC.48.3.946-953.2004"},{"key":"key\n\t\t\t\t20171012225126_B290","doi-asserted-by":"crossref","unstructured":"Huda N, Lee EW, Chen J et al. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob Agents Chemother2003; 47: 2413\u20137.","DOI":"10.1128\/AAC.47.8.2413-2417.2003"},{"key":"key\n\t\t\t\t20171012225126_B291","doi-asserted-by":"crossref","unstructured":"Yang S, Clayton SR, Zechiedrich EL. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother2003; 51: 545\u201356.","DOI":"10.1093\/jac\/dkg126"},{"key":"key\n\t\t\t\t20171012225126_B292","doi-asserted-by":"crossref","unstructured":"Chan YY, Tan TM, Ong YM et al. BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob Agents Chemother2004; 48: 1128\u201335.","DOI":"10.1128\/AAC.48.4.1128-1135.2004"},{"key":"key\n\t\t\t\t20171012225126_B293","doi-asserted-by":"crossref","unstructured":"Li X-Z, Poole K, Nikaido H. Contributions of MexAB-OprM and an EmrE homologue to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother2003; 47: 27\u201333.","DOI":"10.1128\/AAC.47.1.27-33.2003"},{"key":"key\n\t\t\t\t20171012225126_B294","doi-asserted-by":"crossref","unstructured":"Miller GH, Sabatelli FJ, Naples L et al. Resistance to aminoglycosides in Pseudomonas. Aminoglycoside Resistance Study Groups. Trends Microbiol1994; 2: 347\u201353.","DOI":"10.1016\/0966-842X(94)90609-2"},{"key":"key\n\t\t\t\t20171012225126_B295","unstructured":"Miller GH, Sabatelli FJ, Naples L et al. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin\u2014a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. J Chemother1995; 7 Suppl 2: 31\u201344."},{"key":"key\n\t\t\t\t20171012225126_B296","unstructured":"Miller GH, Sabatelli FJ, Naples L et al. The most frequently occurring aminoglycoside resistance mechanisms\u2014combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups. J Chemother1995; 7 Suppl 2: 17\u201330."},{"key":"key\n\t\t\t\t20171012225126_B297","doi-asserted-by":"crossref","unstructured":"Price KE, Kresel PA, Farchione LA et al. Epidemiological studies of aminoglycoside resistance in the U.S.A. J Antimicrob Chemother1981; 8 Suppl A: 89\u2013105.","DOI":"10.1093\/jac\/8.suppl_A.89"},{"key":"key\n\t\t\t\t20171012225126_B298","doi-asserted-by":"crossref","unstructured":"Phillips I, King A, Shannon K. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. Am J Med1986; 80: 48\u201355.","DOI":"10.1016\/0002-9343(86)90479-1"},{"key":"key\n\t\t\t\t20171012225126_B299","doi-asserted-by":"crossref","unstructured":"Shimizu K, Kumada T, Hsieh WC et al. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother1985; 28: 282\u20138.","DOI":"10.1128\/AAC.28.2.282"},{"key":"key\n\t\t\t\t20171012225126_B300","doi-asserted-by":"crossref","unstructured":"MacLeod DL, Nelson LE, Shawar RM et al. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J Infect Dis2000; 181: 1180\u20134.","DOI":"10.1086\/315312"},{"key":"key\n\t\t\t\t20171012225126_B301","doi-asserted-by":"crossref","unstructured":"Hurley JC, Miller GH, Smith AL. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Diagn Microbiol Infect Dis1995; 22: 331\u20136.","DOI":"10.1016\/0732-8893(95)00138-6"},{"key":"key\n\t\t\t\t20171012225126_B302","doi-asserted-by":"crossref","unstructured":"LiPuma JJ. Microbiological and immunologic considerations with aerosolized drug delivery. Chest2001; 120: 118S\u2013123S.","DOI":"10.1378\/chest.120.3_suppl.118S"},{"key":"key\n\t\t\t\t20171012225126_B303","doi-asserted-by":"crossref","unstructured":"Saiman L, Mehar F, Niu WW et al. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis1996; 23: 532\u20137.","DOI":"10.1093\/clinids\/23.3.532"},{"key":"key\n\t\t\t\t20171012225126_B304","doi-asserted-by":"crossref","unstructured":"Shawar RM, MacLeod DL, Garber RL et al. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother1999; 43: 2877\u201380.","DOI":"10.1128\/AAC.43.12.2877"},{"key":"key\n\t\t\t\t20171012225126_B305","doi-asserted-by":"crossref","unstructured":"Kettner M, Milosovic P, Hletkova M et al. Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates. Infection1995; 23: 380\u20133.","DOI":"10.1007\/BF01713571"},{"key":"key\n\t\t\t\t20171012225126_B306","doi-asserted-by":"crossref","unstructured":"Sobel ML, McKay GA, Poole K. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother2003; 47: 3202\u20137.","DOI":"10.1128\/AAC.47.10.3202-3207.2003"},{"key":"key\n\t\t\t\t20171012225126_B307","doi-asserted-by":"crossref","unstructured":"Vogne C, Aires JR, Bailly C et al. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother2004; 48: 1676\u201380.","DOI":"10.1128\/AAC.48.5.1676-1680.2004"},{"key":"key\n\t\t\t\t20171012225126_B308","doi-asserted-by":"crossref","unstructured":"Westbrock-Wadman S, Sherman DR, Hickey MJ et al. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother1999; 43: 2975\u201383.","DOI":"10.1128\/AAC.43.12.2975"},{"key":"key\n\t\t\t\t20171012225126_B309","doi-asserted-by":"crossref","unstructured":"Deplano A, Denis O, Poirel L et al. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol2005; 43: 1198\u2013204.","DOI":"10.1128\/JCM.43.3.1198-1204.2005"},{"key":"key\n\t\t\t\t20171012225126_B310","doi-asserted-by":"crossref","unstructured":"Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother2005; 49: 479\u201387.","DOI":"10.1128\/AAC.49.2.479-487.2005"},{"key":"key\n\t\t\t\t20171012225126_B311","doi-asserted-by":"crossref","unstructured":"Hocquet D, Vogne C, El Garch F et al. MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother2003; 47: 1371\u20135.","DOI":"10.1128\/AAC.47.4.1371-1375.2003"},{"key":"key\n\t\t\t\t20171012225126_B312","doi-asserted-by":"crossref","unstructured":"Karlowsky JA, Zelenitsky SA, Zhanel GG. Aminoglycoside adaptive resistance. Pharmacotherapy1997; 17: 549\u201355.","DOI":"10.1002\/j.1875-9114.1997.tb03063.x"},{"key":"key\n\t\t\t\t20171012225126_B313","doi-asserted-by":"crossref","unstructured":"Okamoto K, Gotoh N, Nishino T. Alterations of susceptibility of Pseudomonas aeruginosa by overproduction of multidrug efflux systems, MexAB-OprM, MexCD-OprJ, and MexXY\/OprM to carbapenems: substrate specificities of the efflux systems. J Infect Chemother2002; 8: 371\u20133.","DOI":"10.1007\/s10156-002-0193-7"},{"key":"key\n\t\t\t\t20171012225126_B314","doi-asserted-by":"crossref","unstructured":"Okamoto K, Gotoh N, Nishino T. Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa. Antimicrob Agents Chemother2002; 46: 2696\u20139.","DOI":"10.1128\/AAC.46.8.2696-2699.2002"},{"key":"key\n\t\t\t\t20171012225126_B315","doi-asserted-by":"crossref","unstructured":"Mazzariol A, Cornaglia G, Nikaido H. Contributions of the AmpC \u03b2-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to \u03b2-lactams. Antimicrob Agents Chemother2000; 44: 1387\u201390.","DOI":"10.1128\/AAC.44.5.1387-1390.2000"},{"key":"key\n\t\t\t\t20171012225126_B316","doi-asserted-by":"crossref","unstructured":"Masuda N, Gotoh N, Ishii C et al. Interplay between chromosomal \u03b2-lactamase and the MexAB-OprM efflux system in intrinsic resistance to \u03b2-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother1999; 43: 400\u20132.","DOI":"10.1128\/AAC.43.2.400"},{"key":"key\n\t\t\t\t20171012225126_B317","doi-asserted-by":"crossref","unstructured":"Masuda N, Sakagawa E, Ohya S et al. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother2000; 44: 3322\u20137.","DOI":"10.1128\/AAC.44.12.3322-3327.2000"},{"key":"key\n\t\t\t\t20171012225126_B318","doi-asserted-by":"crossref","unstructured":"Nikaido H, Basina M, Nguyen V et al. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those \u03b2-lactam antibiotics containing lipophilic side chains. J Bacteriol1998; 180: 4686\u201392.","DOI":"10.1128\/JB.180.17.4686-4692.1998"},{"key":"key\n\t\t\t\t20171012225126_B319","doi-asserted-by":"crossref","unstructured":"Nishino K, Yamada J, Hirakawa H et al. Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to \u03b2-lactams. Antimicrob Agents Chemother2003; 47: 3030\u20133.","DOI":"10.1128\/AAC.47.9.3030-3033.2003"},{"key":"key\n\t\t\t\t20171012225126_B320","doi-asserted-by":"crossref","unstructured":"Hirakawa H, Nishino K, Yamada J et al. \u03b2-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Antimicrob Chemother2003; 52: 576\u201382.","DOI":"10.1093\/jac\/dkg406"},{"key":"key\n\t\t\t\t20171012225126_B321","doi-asserted-by":"crossref","unstructured":"Poole K. Resistance to \u03b2-lactam antibiotics. Cell Mol Life Sci2004; 61: 2200\u201323.","DOI":"10.1007\/s00018-004-4060-9"},{"key":"key\n\t\t\t\t20171012225126_B322","doi-asserted-by":"crossref","unstructured":"Pai H, Kim J, Kim J et al. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother2001; 45: 480\u20134.","DOI":"10.1128\/AAC.45.2.480-484.2001"},{"key":"key\n\t\t\t\t20171012225126_B323","doi-asserted-by":"crossref","unstructured":"Boutoille D, Corvec S, Caroff N et al. Detection of an IS21 insertion sequence in the mexR gene of Pseudomonas aeruginosa increasing \u03b2-lactam resistance. FEMS Microbiol Lett2004; 230: 143\u20136.","DOI":"10.1016\/S0378-1097(03)00882-6"},{"key":"key\n\t\t\t\t20171012225126_B324","doi-asserted-by":"crossref","unstructured":"Cavallo JD, Plesiat P, Couetdic G et al. Mechanisms of \u03b2-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproducing strains in a French multicentre study (1997). J Antimicrob Chemother2002; 50: 1039\u201343.","DOI":"10.1093\/jac\/dkf186"},{"key":"key\n\t\t\t\t20171012225126_B325","unstructured":"Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol2001; 3: 255\u201364."},{"key":"key\n\t\t\t\t20171012225126_B326","doi-asserted-by":"crossref","unstructured":"K\u00f6hler T, Epp SF, Curty LK et al. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol1999; 181: 6300\u20135.","DOI":"10.1128\/JB.181.20.6300-6305.1999"},{"key":"key\n\t\t\t\t20171012225126_B327","doi-asserted-by":"crossref","unstructured":"Ochs MM, McCusker MP, Bains M et al. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob Agents Chemother1999; 43: 1085\u201390.","DOI":"10.1128\/AAC.43.5.1085"},{"key":"key\n\t\t\t\t20171012225126_B328","doi-asserted-by":"crossref","unstructured":"Wolter DJ, Hanson ND, Lister PD. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol Lett2004; 236: 137\u201343.","DOI":"10.1111\/j.1574-6968.2004.tb09639.x"},{"key":"key\n\t\t\t\t20171012225126_B329","doi-asserted-by":"crossref","unstructured":"Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother2001; 47: 247\u201350.","DOI":"10.1093\/jac\/47.3.247"},{"key":"key\n\t\t\t\t20171012225126_B330","doi-asserted-by":"crossref","unstructured":"Veal WL, Nicholas RA, Shafer WM. Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol2002; 184: 5619\u201324.","DOI":"10.1128\/JB.184.20.5619-5624.2002"},{"key":"key\n\t\t\t\t20171012225126_B331","doi-asserted-by":"crossref","unstructured":"Kaczmarek FS, Gootz TD, Dib-Hajj F et al. Genetic and molecular characterization of \u03b2-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob Agents Chemother2004; 48: 1630\u20139.","DOI":"10.1128\/AAC.48.5.1630-1639.2004"},{"key":"key\n\t\t\t\t20171012225126_B332","doi-asserted-by":"crossref","unstructured":"Kallman O, Fendukly F, Karlsson I et al. Contribution of efflux to cefuroxime resistance in clinical isolates of Escherichia coli. Scand J Infect Dis2003; 35: 464\u201370.","DOI":"10.1080\/00365540310014639"},{"key":"key\n\t\t\t\t20171012225126_B333","doi-asserted-by":"crossref","unstructured":"Fujisaki S, Ohnuma S, Horiuchi T et al. Cloning of a gene from Escherichia coli that confers resistance to fosmidomycin as a consequence of amplification. Gene1996; 175: 83\u20137.","DOI":"10.1016\/0378-1119(96)00128-X"},{"key":"key\n\t\t\t\t20171012225126_B334","doi-asserted-by":"crossref","unstructured":"Turnidge J, Collignon P. Resistance to fusidic acid. Int J Antimicrob Agents1999; 12 Suppl 2: S35\u2013S44.","DOI":"10.1016\/S0924-8579(98)00072-7"},{"key":"key\n\t\t\t\t20171012225126_B335","doi-asserted-by":"crossref","unstructured":"Ramos JL, Duque E, Gallegos MT et al. Mechanisms of solvent tolerance in gram-negative bacteria. Annu Rev Microbiol2002; 56: 743\u201368.","DOI":"10.1146\/annurev.micro.56.012302.161038"},{"key":"key\n\t\t\t\t20171012225126_B336","doi-asserted-by":"crossref","unstructured":"Fernandes P, Ferreira BS, Cabral JM. Solvent tolerance in bacteria: role of efflux pumps and cross-resistance with antibiotics. Int J Antimicrob Agents2003; 22: 211\u20136.","DOI":"10.1016\/S0924-8579(03)00209-7"},{"key":"key\n\t\t\t\t20171012225126_B337","doi-asserted-by":"crossref","unstructured":"Randall LP, Cooles SW, Sayers AR et al. Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyes. J Med Microbiol2001; 50: 919\u201324.","DOI":"10.1099\/0022-1317-50-10-919"},{"key":"key\n\t\t\t\t20171012225126_B338","doi-asserted-by":"crossref","unstructured":"Zhao S, Maurer JJ, Hubert S et al. Antimicrobial susceptibility and molecular characterization of avian pathogenic Escherichia coli isolates. Vet Microbiol 2005; 107: 215\u201324.","DOI":"10.1016\/j.vetmic.2005.01.021"},{"key":"key\n\t\t\t\t20171012225126_B339","doi-asserted-by":"crossref","unstructured":"Jude F, Arpin C, Brachet-Castang C et al. TbtABM, a multidrug efflux pump associated with tributyltin resistance in Pseudomonas stutzeri. FEMS Microbiol Lett2004; 232: 7\u201314.","DOI":"10.1016\/S0378-1097(04)00012-6"},{"key":"key\n\t\t\t\t20171012225126_B340","doi-asserted-by":"crossref","unstructured":"Nies DH. Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol Rev2003; 27: 313\u201339.","DOI":"10.1016\/S0168-6445(03)00048-2"},{"key":"key\n\t\t\t\t20171012225126_B341","doi-asserted-by":"crossref","unstructured":"Poole K. Acquired resistance. In Fraise AP, Lambert PA, Maillard J-Y, eds. Russell, Hugo & Ayliffe's Principles and Practice of Disinfection, Preservation & Sterilization. Oxford: Blackwell Publishing, 2004; 170\u201383.","DOI":"10.1002\/9780470755884.ch6b"},{"key":"key\n\t\t\t\t20171012225126_B342","doi-asserted-by":"crossref","unstructured":"Leelaporn A, Paulsen IT, Tennent JM et al. Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. J Med Microbiol1994; 40: 214\u201320.","DOI":"10.1099\/00222615-40-3-214"},{"key":"key\n\t\t\t\t20171012225126_B343","doi-asserted-by":"crossref","unstructured":"Noguchi N, Hase M, Kitta M et al. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett1999; 172: 247\u201353.","DOI":"10.1111\/j.1574-6968.1999.tb13475.x"},{"key":"key\n\t\t\t\t20171012225126_B344","doi-asserted-by":"crossref","unstructured":"Kazama H, Hamashima H, Sasatsu M et al. Distribution of the antiseptic-resistance gene qacE\u03941 in gram-positive bacteria. FEMS Microbiol Lett1998; 165: 295\u20139.","DOI":"10.1016\/S0378-1097(98)00291-2"},{"key":"key\n\t\t\t\t20171012225126_B345","doi-asserted-by":"crossref","unstructured":"Bjorland J, Steinum T, Sunde M et al. Novel plasmid-borne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius. Antimicrob Agents Chemother2003; 47: 3046\u201352.","DOI":"10.1128\/AAC.47.10.3046-3052.2003"},{"key":"key\n\t\t\t\t20171012225126_B346","doi-asserted-by":"crossref","unstructured":"Bjorland J, Sunde M, Waage S. Plasmid-borne smr gene causes resistance to quaternary ammonium compounds in bovine Staphylococcus aureus. J Clin Microbiol2001; 39: 3999\u20134004.","DOI":"10.1128\/JCM.39.11.3999-4004.2001"},{"key":"key\n\t\t\t\t20171012225126_B347","doi-asserted-by":"crossref","unstructured":"Heir E, Sundheim G, Holck AL. Identification and characterization of quaternary ammonium compound resistant staphylococci from the food industry. Int J Food Microbiol1999; 48: 211\u20139.","DOI":"10.1016\/S0168-1605(99)00044-6"},{"key":"key\n\t\t\t\t20171012225126_B348","doi-asserted-by":"crossref","unstructured":"Sidhu MS, Heir E, Sorum H et al. Genetic linkage between resistance to quaternary ammonium compounds and \u03b2-lactam antibiotics in food-related Staphylococcus spp. Microb Drug Resist2001; 7: 363\u201371.","DOI":"10.1089\/10766290152773374"},{"key":"key\n\t\t\t\t20171012225126_B349","doi-asserted-by":"crossref","unstructured":"Heir E, Sundheim G, Holck AL. Resistance to quaternary ammonium compounds in Staphylococcus spp. isolated from the food industry and nucleotide sequence of the resistance plasmid pST827. J Appl Bacteriol1995; 79: 149\u201356.","DOI":"10.1111\/j.1365-2672.1995.tb00928.x"},{"key":"key\n\t\t\t\t20171012225126_B350","doi-asserted-by":"crossref","unstructured":"Noguchi N, Tamura M, Narui K et al. Frequency and genetic characterization of multidrug-resistant mutants of Staphylococcus aureus after selection with individual antiseptics and fluoroquinolones. Biol Pharm Bull2002; 25: 1129\u201332.","DOI":"10.1248\/bpb.25.1129"},{"key":"key\n\t\t\t\t20171012225126_B351","doi-asserted-by":"crossref","unstructured":"Noguchi N, Okada H, Narui K et al. Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Microb Drug Resist2004; 10: 197\u2013203.","DOI":"10.1089\/mdr.2004.10.197"},{"key":"key\n\t\t\t\t20171012225126_B351A","doi-asserted-by":"crossref","unstructured":"Kaatz GW, McAleese F, Seo SM. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother2005; 49: 1857\u201364.","DOI":"10.1128\/AAC.49.5.1857-1864.2005"},{"key":"key\n\t\t\t\t20171012225126_B352","doi-asserted-by":"crossref","unstructured":"Lee EW, Huda MN, Kuroda T et al. EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis. Antimicrob Agents Chemother2003; 47: 3733\u20138.","DOI":"10.1128\/AAC.47.12.3733-3738.2003"},{"key":"key\n\t\t\t\t20171012225126_B353","doi-asserted-by":"crossref","unstructured":"Kaatz GW, Seo SM, O'Brien L et al. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob Agents Chemother2000; 44: 1404\u20136.","DOI":"10.1128\/AAC.44.5.1404-1406.2000"},{"key":"key\n\t\t\t\t20171012225126_B354","doi-asserted-by":"crossref","unstructured":"Aase B, Sundheim G, Langsrud S et al. Occurrence of and a possible mechanism for resistance to a quaternary ammonium compound in Listeria monocytogenes. Int J Food Microbiol2000; 62: 57\u201363.","DOI":"10.1016\/S0168-1605(00)00357-3"},{"key":"key\n\t\t\t\t20171012225126_B355","doi-asserted-by":"crossref","unstructured":"To MS, Favrin S, Romanova N et al. Postadaptational resistance to benzalkonium chloride and subsequent physicochemical modifications of Listeria monocytogenes. Appl Environ Microbiol2002; 68: 5258\u201364.","DOI":"10.1128\/AEM.68.11.5258-5264.2002"},{"key":"key\n\t\t\t\t20171012225126_B356","doi-asserted-by":"crossref","unstructured":"Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev2003; 27: 341\u201353.","DOI":"10.1016\/S0168-6445(03)00047-0"},{"key":"key\n\t\t\t\t20171012225126_B357","doi-asserted-by":"crossref","unstructured":"Barbolla R, Catalano M, Orman BE et al. Class 1 integrons increase trimethoprim\u2013sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother2004; 48: 666\u20139.","DOI":"10.1128\/AAC.48.2.666-669.2004"},{"key":"key\n\t\t\t\t20171012225126_B358","doi-asserted-by":"crossref","unstructured":"Saenz Y, Brinas L, Dominguez E et al. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother2004; 48: 3996\u20134001.","DOI":"10.1128\/AAC.48.10.3996-4001.2004"},{"key":"key\n\t\t\t\t20171012225126_B359","doi-asserted-by":"crossref","unstructured":"O'Halloran F, Lucey B, Cryan B et al. Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp. J Antimicrob Chemother2004; 53: 952\u20137.","DOI":"10.1093\/jac\/dkh193"},{"key":"key\n\t\t\t\t20171012225126_B360","doi-asserted-by":"crossref","unstructured":"Kucken D, Feucht H, Kaulfers P. Association of qacE and qacE\u03941 with multiple resistance to antibiotics and antiseptics in clinical isolates of Gram-negative bacteria. FEMS Microbiol Lett2000; 183: 95\u20138.","DOI":"10.1016\/S0378-1097(99)00636-9"},{"key":"key\n\t\t\t\t20171012225126_B361","doi-asserted-by":"crossref","unstructured":"Morita Y, Murata T, Mima T et al. Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. J Antimicrob Chemother2003; 5: 991\u20134.","DOI":"10.1093\/jac\/dkg173"},{"key":"key\n\t\t\t\t20171012225126_B362","doi-asserted-by":"crossref","unstructured":"Langsrud S, Sundheim G, Holck AL. Cross-resistance to antibiotics of Escherichia coli adapted to benzalkonium chloride or exposed to stress-inducers. J Appl Microbiol2004; 96: 201\u20138.","DOI":"10.1046\/j.1365-2672.2003.02140.x"},{"key":"key\n\t\t\t\t20171012225126_B363","doi-asserted-by":"crossref","unstructured":"Braoudaki M, Hilton AC. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol2004; 42: 73\u20138.","DOI":"10.1128\/JCM.42.1.73-78.2004"},{"key":"key\n\t\t\t\t20171012225126_B364","doi-asserted-by":"crossref","unstructured":"Braoudaki M, Hilton AC. Mechanisms of resistance in Salmonella enterica adapted to erythromycin, benzalkonium chloride and triclosan. Int J Antimicrob Agents2005; 25: 31\u20137.","DOI":"10.1016\/j.ijantimicag.2004.07.016"},{"key":"key\n\t\t\t\t20171012225126_B365","doi-asserted-by":"crossref","unstructured":"Yerushalmi H, Lebendiker M, Schuldiner S. EmrE, an Escherichia coli 12-kDa multidrug transporter, exchanges toxic cations and H+ and is soluble in organic solvents. J Biol Chem1995; 270: 6856\u201363.","DOI":"10.1074\/jbc.270.12.6856"},{"key":"key\n\t\t\t\t20171012225126_B366","doi-asserted-by":"crossref","unstructured":"Nishino K, Yamaguchi A. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol2001; 183: 5803\u201312.","DOI":"10.1128\/JB.183.20.5803-5812.2001"},{"key":"key\n\t\t\t\t20171012225126_B367","doi-asserted-by":"crossref","unstructured":"Nagai K, Murata T, Ohta S et al. Two different mechanisms are involved in the extremely high-level benzalkonium chloride resistance of a Pseudomonas fluorescens strain. Microbiol Immunol2003; 47: 709\u201315.","DOI":"10.1111\/j.1348-0421.2003.tb03440.x"},{"key":"key\n\t\t\t\t20171012225126_B368","doi-asserted-by":"crossref","unstructured":"Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev2004; 17: 863\u201393, table.","DOI":"10.1128\/CMR.17.4.863-893.2004"},{"key":"key\n\t\t\t\t20171012225126_B369","doi-asserted-by":"crossref","unstructured":"Fang C-T, Chen H-C, Chuang Y-P et al. Cloning of a cation efflux pump gene associated with chlorhexidine resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother2002; 46: 2024\u20138.","DOI":"10.1128\/AAC.46.6.2024-2028.2002"},{"key":"key\n\t\t\t\t20171012225126_B370","doi-asserted-by":"crossref","unstructured":"Braoudaki M, Hilton AC. Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157. FEMS Microbiol Lett2004; 235: 305\u20139.","DOI":"10.1111\/j.1574-6968.2004.tb09603.x"},{"key":"key\n\t\t\t\t20171012225126_B371","doi-asserted-by":"crossref","unstructured":"Chuanchuen R, Karkhoff-Schweizer RR, Schweizer HP. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control2003; 31: 124\u20137.","DOI":"10.1067\/mic.2003.11"},{"key":"key\n\t\t\t\t20171012225126_B372","doi-asserted-by":"crossref","unstructured":"Chen J, Kuroda T, Huda MN et al. An RND-type multidrug efflux pump SdeXY from Serratia marcescens. J Antimicrob Chemother2003; 52: 176\u20139.","DOI":"10.1093\/jac\/dkg308"},{"key":"key\n\t\t\t\t20171012225126_B373","doi-asserted-by":"crossref","unstructured":"Sanchez P, Moreno E, Martinez JL. The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother2005; 49: 781\u20132.","DOI":"10.1128\/AAC.49.2.781-782.2005"},{"key":"key\n\t\t\t\t20171012225126_B374","doi-asserted-by":"crossref","unstructured":"McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett1998; 166: 305\u20139.","DOI":"10.1111\/j.1574-6968.1998.tb13905.x"},{"key":"key\n\t\t\t\t20171012225126_B374A","doi-asserted-by":"crossref","unstructured":"Pumbwe L, Randall LP, Woodward MJ et al. Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF. Antimicrob Agents Chemother2005; 49: 1289\u201393.","DOI":"10.1128\/AAC.49.4.1289-1293.2005"},{"key":"key\n\t\t\t\t20171012225126_B375","doi-asserted-by":"crossref","unstructured":"Randall LP, Cooles SW, Piddock LJ et al. Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. J Antimicrob Chemother2004; 54: 621\u20137.","DOI":"10.1093\/jac\/dkh376"},{"key":"key\n\t\t\t\t20171012225126_B376","doi-asserted-by":"crossref","unstructured":"Randall LP, Ridley AM, Cooles SW et al. Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals. J Antimicrob Chemother2003; 52: 507\u201310.","DOI":"10.1093\/jac\/dkg379"},{"key":"key\n\t\t\t\t20171012225126_B377","doi-asserted-by":"crossref","unstructured":"Ikeda T, Yoshimura F. A resistance-nodulation-cell division family xenobiotic efflux pump in an obligate anaerobe, Porphyromonas gingivalis. Antimicrob Agents Chemother2002; 46: 3257\u201360.","DOI":"10.1128\/AAC.46.10.3257-3260.2002"},{"key":"key\n\t\t\t\t20171012225126_B378","doi-asserted-by":"crossref","unstructured":"Betts JC, McLaren A, Lennon MG et al. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob Agents Chemother2003; 47: 2903\u201313.","DOI":"10.1128\/AAC.47.9.2903-2913.2003"},{"key":"key\n\t\t\t\t20171012225126_B379","doi-asserted-by":"crossref","unstructured":"Gupta A, Phung LT, Taylor DE et al. Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology2001; 147: 3393\u2013402.","DOI":"10.1099\/00221287-147-12-3393"},{"key":"key\n\t\t\t\t20171012225126_B380","doi-asserted-by":"crossref","unstructured":"Gilmour MW, Thomson NR, Sanders M et al. The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics. Plasmid2004; 52: 182\u2013202.","DOI":"10.1016\/j.plasmid.2004.06.006"},{"key":"key\n\t\t\t\t20171012225126_B381","doi-asserted-by":"crossref","unstructured":"Chen YT, Chang HY, Lai YC et al. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene2004; 337: 189\u201398.","DOI":"10.1016\/j.gene.2004.05.008"},{"key":"key\n\t\t\t\t20171012225126_B382","doi-asserted-by":"crossref","unstructured":"Moken MC, McMurry LM, Levy SB. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob Agents Chemother1997; 41: 2770\u20132.","DOI":"10.1128\/AAC.41.12.2770"},{"key":"key\n\t\t\t\t20171012225126_B383","doi-asserted-by":"crossref","unstructured":"Gilbert P, McBain AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev2003; 16: 189\u2013208.","DOI":"10.1128\/CMR.16.2.189-208.2003"},{"key":"key\n\t\t\t\t20171012225126_B384","doi-asserted-by":"crossref","unstructured":"Fraise AP. Reply. J Antimicrob Chemother2002; 50: 139\u201340.","DOI":"10.1093\/jac\/dkf070"},{"key":"key\n\t\t\t\t20171012225126_B385","doi-asserted-by":"crossref","unstructured":"Fraise AP. Biocide abuse and antimicrobial resistance\u2014a cause for concern? J Antimicrob Chemother2002; 49: 11\u20132.","DOI":"10.1093\/jac\/49.1.11"},{"key":"key\n\t\t\t\t20171012225126_B386","doi-asserted-by":"crossref","unstructured":"Gilbert P, McBain AJ. Biocide usage in the domestic setting and concern about antibacterial and antibiotic resistance. J Infect2001; 43: 85\u201391.","DOI":"10.1016\/S0163-4453(01)90853-9"},{"key":"key\n\t\t\t\t20171012225126_B387","doi-asserted-by":"crossref","unstructured":"Gilbert P, McBain AJ, Bloomfield SF. Biocide abuse and antimicrobial resistance: being clear about the issues. J Antimicrob Chemother2002; 50: 137\u20139.","DOI":"10.1093\/jac\/dkf071"},{"key":"key\n\t\t\t\t20171012225126_B388","doi-asserted-by":"crossref","unstructured":"McBain AJ, Rickard AH, Gilbert P. Possible implications of biocide accumulation in the environment on the prevalence of bacterial antibiotic resistance. J Ind Microbiol Biotechnol2002; 29: 326\u201330.","DOI":"10.1038\/sj.jim.7000324"},{"key":"key\n\t\t\t\t20171012225126_B389","doi-asserted-by":"crossref","unstructured":"Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistance. J Appl Microbiol2002; 92 Suppl: 65S\u201371S.","DOI":"10.1046\/j.1365-2672.92.5s1.4.x"},{"key":"key\n\t\t\t\t20171012225126_B390","doi-asserted-by":"crossref","unstructured":"Chuanchuen R, Beinlich K, Hoang TT et al. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother2001; 45: 428\u201332.","DOI":"10.1128\/AAC.45.2.428-432.2001"},{"key":"key\n\t\t\t\t20171012225126_B391","doi-asserted-by":"crossref","unstructured":"Chuanchuen R, Narasaki CT, Schweizer HP. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J Bacteriol2002; 184: 5036\u201344.","DOI":"10.1128\/JB.184.18.5036-5044.2002"},{"key":"key\n\t\t\t\t20171012225126_B392","doi-asserted-by":"crossref","unstructured":"Cole EC, Addison RM, Rubino JR et al. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J Appl Microbiol2003; 95: 664\u201376.","DOI":"10.1046\/j.1365-2672.2003.02022.x"},{"key":"key\n\t\t\t\t20171012225126_B393","doi-asserted-by":"crossref","unstructured":"Mosher RH, Camp DJ, Yang K et al. Inactivation of chloramphenicol by O-phosphorylation. A novel resistance mechanism in Streptomyces venezuelae ISP5230, a chloramphenicol producer. J Biol Chem1995; 270: 27000\u20136.","DOI":"10.1074\/jbc.270.45.27000"},{"key":"key\n\t\t\t\t20171012225126_B394","doi-asserted-by":"crossref","unstructured":"Peschke U, Schmidt H, Zhang HZ et al. Molecular characterization of the lincomycin-production gene cluster of Streptomyces lincolnensis 78-11. Mol Microbiol1995; 16: 1137\u201356.","DOI":"10.1111\/j.1365-2958.1995.tb02338.x"},{"key":"key\n\t\t\t\t20171012225126_B395","doi-asserted-by":"crossref","unstructured":"Guilfoile PG, Hutchinson CR. Sequence and transcriptional analysis of the Streptomyces glaucescens tcmAR tetracenomycin C resistance and repressor gene loci. J Bacteriol1992; 174: 3651\u20138.","DOI":"10.1128\/jb.174.11.3651-3658.1992"},{"key":"key\n\t\t\t\t20171012225126_B396","doi-asserted-by":"crossref","unstructured":"Neal RJ, Chater KF. Nucleotide sequence analysis reveals similarities between proteins determining methylenomycin A resistance in Streptomyces and tetracycline resistance in eubacteria. Gene1987; 58: 229\u201341.","DOI":"10.1016\/0378-1119(87)90378-7"},{"key":"key\n\t\t\t\t20171012225126_B397","doi-asserted-by":"crossref","unstructured":"Caballero JL, Malpartida F, Hopwood DA. Transcriptional organization and regulation of an antibiotic export complex in the producing Streptomyces culture. Mol Gen Genet1991; 228: 372\u201380.","DOI":"10.1007\/BF00260629"},{"key":"key\n\t\t\t\t20171012225126_B398","doi-asserted-by":"crossref","unstructured":"Blanc V, Salah-Bey K, Folcher M et al. Molecular characterization and transcriptional analysis of a multidrug resistance gene cloned from the pristinamycin-producing organism, Streptomyces pristinaespiralis. Mol Microbiol1995; 17: 989\u201399.","DOI":"10.1111\/j.1365-2958.1995.mmi_17050989.x"},{"key":"key\n\t\t\t\t20171012225126_B399","doi-asserted-by":"crossref","unstructured":"Tercero JA, Lacalle RA, Jimenez A. The pur8 gene from the pur cluster of Streptomyces alboniger encodes a highly hydrophobic polypeptide which confers resistance to puromycin. Eur J Biochem1993; 218: 963\u201371.","DOI":"10.1111\/j.1432-1033.1993.tb18454.x"},{"key":"key\n\t\t\t\t20171012225126_B400","doi-asserted-by":"crossref","unstructured":"Aparicio JF, Fouces R, Mendes MV et al. A complex multienzyme system encoded by five polyketide synthase genes is involved in the biosynthesis of the 26-membered polyene macrolide pimaricin in Streptomyces natalensis. Chem Biol2000; 7: 895\u2013905.","DOI":"10.1016\/S1074-5521(00)00038-7"},{"key":"key\n\t\t\t\t20171012225126_B401","doi-asserted-by":"crossref","unstructured":"Mendez C, Salas JA. ABC transporters in antibiotic-producing actinomycetes. FEMS Microbiol Lett1998; 158: 1\u20138.","DOI":"10.1016\/S0378-1097(97)00434-5"},{"key":"key\n\t\t\t\t20171012225126_B402","doi-asserted-by":"crossref","unstructured":"Fierro JF, Hardisson C, Salas JA. Resistance to oleandomycin in Streptomyces antibioticus, the producer organism. J Gen Microbiol1987; 133: 1931\u20139.","DOI":"10.1099\/00221287-133-7-1931"},{"key":"key\n\t\t\t\t20171012225126_B403","doi-asserted-by":"crossref","unstructured":"Sheridan RP, Chopra I. Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis. Mol Microbiol1991; 5: 895\u2013900.","DOI":"10.1111\/j.1365-2958.1991.tb00763.x"},{"key":"key\n\t\t\t\t20171012225126_B404","doi-asserted-by":"crossref","unstructured":"Grkovic S, Brown MH, Skurray RA. Regulation of bacterial drug export systems. Microbiol Mol Biol Rev2002; 66: 671\u2013701.","DOI":"10.1128\/MMBR.66.4.671-701.2002"},{"key":"key\n\t\t\t\t20171012225126_B405","doi-asserted-by":"crossref","unstructured":"Matsuo Y, Eda S, Gotoh N et al. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol Lett2004; 238: 23\u20138.","DOI":"10.1016\/j.femsle.2004.07.010"},{"key":"key\n\t\t\t\t20171012225126_B406","doi-asserted-by":"crossref","unstructured":"Morita Y, Komori Y, Mima T et al. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump. FEMS Microbiol Lett2001; 202: 139\u201343.","DOI":"10.1111\/j.1574-6968.2001.tb10794.x"},{"key":"key\n\t\t\t\t20171012225126_B407","doi-asserted-by":"crossref","unstructured":"Ma D, Cook DN, Alberti M et al. Genes acrA and acrB encode a stress-induced system of Escherichia coli. Mol Microbiol1995; 16: 45\u201355.","DOI":"10.1111\/j.1365-2958.1995.tb02390.x"},{"key":"key\n\t\t\t\t20171012225126_B408","doi-asserted-by":"crossref","unstructured":"Rosenberg EY, Bertenthal D, Nilles ML et al. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol2003; 48: 1609\u201319.","DOI":"10.1046\/j.1365-2958.2003.03531.x"},{"key":"key\n\t\t\t\t20171012225126_B409","doi-asserted-by":"crossref","unstructured":"Thanassi DG, Cheng LW, Nikaido H. Active efflux of bile salts in Escherichia coli. J Bacteriol1997; 179: 2512\u20138.","DOI":"10.1128\/jb.179.8.2512-2518.1997"},{"key":"key\n\t\t\t\t20171012225126_B410","doi-asserted-by":"crossref","unstructured":"Shafer WM, Balthazar JT, Hagman KE et al. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to fecal lipids. Microbiology1995; 141: 907\u201311.","DOI":"10.1099\/13500872-141-4-907"},{"key":"key\n\t\t\t\t20171012225126_B411","doi-asserted-by":"crossref","unstructured":"Hagman KE, Pan W, Spratt BG et al. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology1995; 141: 611\u201322.","DOI":"10.1099\/13500872-141-3-611"},{"key":"key\n\t\t\t\t20171012225126_B411A","doi-asserted-by":"crossref","unstructured":"Lin J, Sahin O, Michel LO et al. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun2003; 71: 4250\u20139.","DOI":"10.1128\/IAI.71.8.4250-4259.2003"},{"key":"key\n\t\t\t\t20171012225126_B412","doi-asserted-by":"crossref","unstructured":"Prouty AM, Brodsky IE, Falkow S et al. Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium. Microbiology2004; 150: 775\u201383.","DOI":"10.1099\/mic.0.26769-0"},{"key":"key\n\t\t\t\t20171012225126_B413","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Chaudhuri S, Saha G et al. Effect of bile on the cell surface permeability barrier and efflux system of Vibrio cholerae. J Bacteriol2004; 186: 6809\u201314.","DOI":"10.1128\/JB.186.20.6809-6814.2004"},{"key":"key\n\t\t\t\t20171012225126_B414","doi-asserted-by":"crossref","unstructured":"Nagakubo S, Nishino K, Hirata T et al. The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC. J Bacteriol2002; 184: 4161\u20137.","DOI":"10.1128\/JB.184.15.4161-4167.2002"},{"key":"key\n\t\t\t\t20171012225126_B415","doi-asserted-by":"crossref","unstructured":"Poole K. Bacterial multidrug resistance\u2014emphasis on efflux mechanisms and Pseudomonas aeruginosa. J Antimicrob Chemother1994; 34: 453\u20136.","DOI":"10.1093\/jac\/34.4.453"},{"key":"key\n\t\t\t\t20171012225126_B416","doi-asserted-by":"crossref","unstructured":"Helling RB, Janes BK, Kimball H et al. Toxic waste disposal in Escherichia coli. J Bacteriol2002; 184: 3699\u2013703.","DOI":"10.1128\/JB.184.13.3699-3703.2002"},{"key":"key\n\t\t\t\t20171012225126_B417","doi-asserted-by":"crossref","unstructured":"Palumbo JD, Kado CI, Phillips DA. An isoflavonoid-inducible efflux pump in Agrobacterium tumefaciens is involved in competitive colonization of roots. J Bacteriol1998; 180: 3107\u201313.","DOI":"10.1128\/JB.180.12.3107-3113.1998"},{"key":"key\n\t\t\t\t20171012225126_B418","doi-asserted-by":"crossref","unstructured":"Burse A, Weingart H, Ullrich MS. The phytoalexin-inducible multidrug efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia amylovora. Mol Plant Microbe Interact2004; 17: 43\u201354.","DOI":"10.1094\/MPMI.2004.17.1.43"},{"key":"key\n\t\t\t\t20171012225126_B419","doi-asserted-by":"crossref","unstructured":"Koretke KK, Lupas AN, Warren PV et al. Evolution of two-component signal transduction. Mol Biol Evol2000; 17: 1956\u201370.","DOI":"10.1093\/oxfordjournals.molbev.a026297"},{"key":"key\n\t\t\t\t20171012225126_B420","doi-asserted-by":"crossref","unstructured":"Li X-Z, Zhang L, Poole K. SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother2002; 46: 333\u201343.","DOI":"10.1128\/AAC.46.2.333-343.2002"},{"key":"key\n\t\t\t\t20171012225126_B421","doi-asserted-by":"crossref","unstructured":"Baranova N, Nikaido H. The BaeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate. J Bacteriol2002; 184: 4168\u201376.","DOI":"10.1128\/JB.184.15.4168-4176.2002"},{"key":"key\n\t\t\t\t20171012225126_B422","doi-asserted-by":"crossref","unstructured":"Eguchi Y, Oshima T, Mori H et al. Transcriptional regulation of drug efflux genes by EvgAS, a two-component system in Escherichia coli. Microbiology2003; 149: 2819\u201328.","DOI":"10.1099\/mic.0.26460-0"},{"key":"key\n\t\t\t\t20171012225126_B423","doi-asserted-by":"crossref","unstructured":"Marchand I, Damier-Piolle L, Courvalin P et al. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother2004; 48: 3298\u2013304.","DOI":"10.1128\/AAC.48.9.3298-3304.2004"},{"key":"key\n\t\t\t\t20171012225126_B424","doi-asserted-by":"crossref","unstructured":"Lee LJ, Barrett JA, Poole RK. Genome-wide transcriptional response of chemostat-cultured Escherichia coli to zinc. J Bacteriol2005; 187: 1124\u201334.","DOI":"10.1128\/JB.187.3.1124-1134.2005"},{"key":"key\n\t\t\t\t20171012225126_B425","doi-asserted-by":"crossref","unstructured":"Cao L, Srikumar R, Poole K. MexAB-OprM hyperexpression in NalC type multidrug resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol Microbiol2004; 53: 1423\u201336.","DOI":"10.1111\/j.1365-2958.2004.04210.x"},{"key":"key\n\t\t\t\t20171012225126_B426","doi-asserted-by":"crossref","unstructured":"Sobel ML, Hocquet D, Cao L et al. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother2005; 49: 1782\u20136.","DOI":"10.1128\/AAC.49.5.1782-1786.2005"},{"key":"key\n\t\t\t\t20171012225126_B427","doi-asserted-by":"crossref","unstructured":"Hirakata Y, Srikumar R, Poole K et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med2002; 196: 109\u201318.","DOI":"10.1084\/jem.20020005"},{"key":"key\n\t\t\t\t20171012225126_B428","doi-asserted-by":"crossref","unstructured":"Sanchez P, Linares JF, Ruiz-Diez B et al. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemother2002; 50: 657\u201364.","DOI":"10.1093\/jac\/dkf185"},{"key":"key\n\t\t\t\t20171012225126_B429","doi-asserted-by":"crossref","unstructured":"Join-Lambert OF, Michea-Hamzehpour M, Kohler T et al. Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Antimicrob Agents Chemother2001; 45: 571\u20136.","DOI":"10.1128\/AAC.45.2.571-576.2001"},{"key":"key\n\t\t\t\t20171012225126_B430","doi-asserted-by":"crossref","unstructured":"Alonso A, Morales G, Escalante R et al. Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J Antimicrob Chemother2004; 53: 432\u20134.","DOI":"10.1093\/jac\/dkh074"},{"key":"key\n\t\t\t\t20171012225126_B431","doi-asserted-by":"crossref","unstructured":"Maseda H, Saito K, Nakajima A et al. Variation of the mexT gene, a regulator of the MexEF-oprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa. FEMS Microbiol Lett2000; 192: 107\u201312.","DOI":"10.1111\/j.1574-6968.2000.tb09367.x"},{"key":"key\n\t\t\t\t20171012225126_B432","doi-asserted-by":"crossref","unstructured":"Sharma KG, Kaur R, Bachhawat AK. The glutathione-mediated detoxification pathway in yeast: an analysis using the red pigment that accumulates in certain adenine biosynthetic mutants of yeasts reveals the involvement of novel genes. Arch Microbiol2003; 180: 108\u201317.","DOI":"10.1007\/s00203-003-0566-z"},{"key":"key\n\t\t\t\t20171012225126_B433","doi-asserted-by":"crossref","unstructured":"Livshits VA, Zakataeva NP, Aleshin VV et al. Identification and characterization of the new gene rhtA involved in threonine and homoserine efflux in Escherichia coli. Res Microbiol2003; 154: 123\u201335.","DOI":"10.1016\/S0923-2508(03)00036-6"},{"key":"key\n\t\t\t\t20171012225126_B434","doi-asserted-by":"crossref","unstructured":"Yen MR, Tseng YH, Simic P et al. The ubiquitous ThrE family of putative transmembrane amino acid efflux transporters. Res Microbiol2002; 153: 19\u201325.","DOI":"10.1016\/S0923-2508(01)01281-5"},{"key":"key\n\t\t\t\t20171012225126_B435","doi-asserted-by":"crossref","unstructured":"Dassler T, Maier T, Winterhalter C et al. Identification of a major facilitator protein from Escherichia coli involved in efflux of metabolites of the cysteine pathway. Mol Microbiol2000; 36: 1101\u201312.","DOI":"10.1046\/j.1365-2958.2000.01924.x"},{"key":"key\n\t\t\t\t20171012225126_B436","doi-asserted-by":"crossref","unstructured":"Bellmann A, Vrljic M, Patek M et al. Expression control and specificity of the basic amino acid exporter LysE of Corynebacterium glutamicum. Microbiology2001; 147: 1765\u201374.","DOI":"10.1099\/00221287-147-7-1765"},{"key":"key\n\t\t\t\t20171012225126_B437","doi-asserted-by":"crossref","unstructured":"Huang H, Hancock RE. Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa. J Bacteriol1993; 175: 7793\u2013800.","DOI":"10.1128\/jb.175.24.7793-7800.1993"},{"key":"key\n\t\t\t\t20171012225126_B438","doi-asserted-by":"crossref","unstructured":"Frisk A, Schurr JR, Wang G et al. Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect Immun2004; 72: 5433\u20138.","DOI":"10.1128\/IAI.72.9.5433-5438.2004"},{"key":"key\n\t\t\t\t20171012225126_B439","doi-asserted-by":"crossref","unstructured":"Juhas M, Wiehlmann L, Huber B et al. Global regulation of quorum sensing and virulence by VqsR in Pseudomonas aeruginosa. Microbiology2004; 150: 831\u201341.","DOI":"10.1099\/mic.0.26906-0"},{"key":"key\n\t\t\t\t20171012225126_B440","doi-asserted-by":"crossref","unstructured":"Cosson P, Zulianello L, Join-Lambert O et al. Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J Bacteriol2002; 184: 3027\u201333.","DOI":"10.1128\/JB.184.11.3027-3033.2002"},{"key":"key\n\t\t\t\t20171012225126_B441","doi-asserted-by":"crossref","unstructured":"Linares JF, Lopez JA, Camafeita E et al. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol2005; 187: 1384\u201391.","DOI":"10.1128\/JB.187.4.1384-1391.2005"},{"key":"key\n\t\t\t\t20171012225126_B441A","doi-asserted-by":"crossref","unstructured":"Ramsey MM, Whiteley M. Pseudomonas aeruginosa attachment and biofilm development in dynamic environments. Mol Microbiol2004; 53: 1075\u201387.","DOI":"10.1111\/j.1365-2958.2004.04181.x"},{"key":"key\n\t\t\t\t20171012225126_B442","doi-asserted-by":"crossref","unstructured":"Ince D, Hooper DC. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus. Antimicrob Agents Chemother2001; 45: 2755\u201364.","DOI":"10.1128\/AAC.45.10.2755-2764.2001"},{"key":"key\n\t\t\t\t20171012225126_B443","doi-asserted-by":"crossref","unstructured":"Ince D, Zhang X, Silver LC et al. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother2002; 46: 3370\u201380.","DOI":"10.1128\/AAC.46.11.3370-3380.2002"},{"key":"key\n\t\t\t\t20171012225126_B444","doi-asserted-by":"crossref","unstructured":"Ince D, Zhang X, Silver LC et al. Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother2003; 47: 274\u201382.","DOI":"10.1128\/AAC.47.1.274-282.2003"},{"key":"key\n\t\t\t\t20171012225126_B445","doi-asserted-by":"crossref","unstructured":"Kerns RJ, Rybak MJ, Kaatz GW et al. Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus. Bioorg Med Chem Lett2003; 13: 1745\u20139.","DOI":"10.1016\/S0960-894X(03)00208-7"},{"key":"key\n\t\t\t\t20171012225126_B446","doi-asserted-by":"crossref","unstructured":"Jacobs MR, Bajaksouzian S, Windau A et al. In vitro activity of the new quinolone WCK 771 against staphylococci. Antimicrob Agents Chemother2004; 48: 3338\u201342.","DOI":"10.1128\/AAC.48.9.3338-3342.2004"},{"key":"key\n\t\t\t\t20171012225126_B447","doi-asserted-by":"crossref","unstructured":"Patel MV, De Souza NJ, Gupte SV et al. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models. Antimicrob Agents Chemother2004; 48: 4754\u201361.","DOI":"10.1128\/AAC.48.12.4754-4761.2004"},{"key":"key\n\t\t\t\t20171012225126_B448","doi-asserted-by":"crossref","unstructured":"Azoulay-Dupuis E, Bedos JP, Mohler J et al. Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model. Antimicrob Agents Chemother2004; 48: 765\u201373.","DOI":"10.1128\/AAC.48.3.765-773.2004"},{"key":"key\n\t\t\t\t20171012225126_B449","doi-asserted-by":"crossref","unstructured":"Grohs P, Houssaye S, Aubert A et al. In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones. Antimicrob Agents Chemother2003; 47: 3542\u20137.","DOI":"10.1128\/AAC.47.11.3542-3547.2003"},{"key":"key\n\t\t\t\t20171012225126_B450","doi-asserted-by":"crossref","unstructured":"Zhanel GG, Hisanaga T, Nichol K et al. Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on Streptococcus pneumoniae. Expert Opin Emerg Drugs2003; 8: 297\u2013321.","DOI":"10.1517\/14728214.8.2.297"},{"key":"key\n\t\t\t\t20171012225126_B451","doi-asserted-by":"crossref","unstructured":"Shortridge VD, Zhong P, Cao Z et al. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci. Antimicrob Agents Chemother2002; 46: 783\u20136.","DOI":"10.1128\/AAC.46.3.783-786.2002"},{"key":"key\n\t\t\t\t20171012225126_B452","doi-asserted-by":"crossref","unstructured":"Hamilton-Miller JM, Shah S. Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes. J Antimicrob Chemother2002; 50: 907\u201313.","DOI":"10.1093\/jac\/dkf237"},{"key":"key\n\t\t\t\t20171012225126_B453","doi-asserted-by":"crossref","unstructured":"Ono T, Kashimura M, Suzuki K et al. In vitro and in vivo antibacterial activities of the tricyclic ketolide TE-802 and its analogs. J Antibiot (Tokyo)2004; 57: 518\u201327.","DOI":"10.7164\/antibiotics.57.518"},{"key":"key\n\t\t\t\t20171012225126_B454","doi-asserted-by":"crossref","unstructured":"Kozlov RS, Bogdanovitch TM, Appelbaum PC et al. Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia. Antimicrob Agents Chemother2002; 46: 2963\u20138.","DOI":"10.1128\/AAC.46.9.2963-2968.2002"},{"key":"key\n\t\t\t\t20171012225126_B455","doi-asserted-by":"crossref","unstructured":"Reinert RR, Lutticken R, Bryskier A et al. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000\u20132001. Antimicrob Agents Chemother2003; 47: 489\u201393.","DOI":"10.1128\/AAC.47.2.489-493.2003"},{"key":"key\n\t\t\t\t20171012225126_B456","doi-asserted-by":"crossref","unstructured":"Canton R, Mazzariol A, Morosini MI et al. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J Antimicrob Chemother2005; 55: 489\u201395.","DOI":"10.1093\/jac\/dki033"},{"key":"key\n\t\t\t\t20171012225126_B457","doi-asserted-by":"crossref","unstructured":"Hershberger E, Donabedian S, Konstantinou K et al. Quinupristin\u2013dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin Infect Dis2004; 38: 92\u20138.","DOI":"10.1086\/380125"},{"key":"key\n\t\t\t\t20171012225126_B458","doi-asserted-by":"crossref","unstructured":"Norcia LJ, Silvia AM, Santoro SL et al. In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens. J Antibiot (Tokyo)2004; 57: 280\u20138.","DOI":"10.7164\/antibiotics.57.280"},{"key":"key\n\t\t\t\t20171012225126_B459","doi-asserted-by":"crossref","unstructured":"Zhanel GG, Homenuik K, Nichol K et al. The glycylcyclines: a comparative review with the tetracyclines. Drugs2004; 64: 63\u201388.","DOI":"10.2165\/00003495-200464010-00005"},{"key":"key\n\t\t\t\t20171012225126_B460","doi-asserted-by":"crossref","unstructured":"Hirata T, Saito A, Nishino K et al. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimicrob Agents Chemother2004; 48: 2179\u201384.","DOI":"10.1128\/AAC.48.6.2179-2184.2004"},{"key":"key\n\t\t\t\t20171012225126_B461","doi-asserted-by":"crossref","unstructured":"Dean CR, Visalli MA, Projan SJ et al. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother2003; 47: 972\u20138.","DOI":"10.1128\/AAC.47.3.972-978.2003"},{"key":"key\n\t\t\t\t20171012225126_B462","doi-asserted-by":"crossref","unstructured":"Visalli MA, Murphy E, Projan SJ et al. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob Agents Chemother2003; 47: 665\u20139.","DOI":"10.1128\/AAC.47.2.665-669.2003"},{"key":"key\n\t\t\t\t20171012225126_B463","doi-asserted-by":"crossref","unstructured":"Ruzin A, Visalli MA, Keeney D et al. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother2005; 49: 1017\u201322.","DOI":"10.1128\/AAC.49.3.1017-1022.2005"},{"key":"key\n\t\t\t\t20171012225126_B464","doi-asserted-by":"crossref","unstructured":"Ruzin A, Keeney D, Bradford PA. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob Agents Chemother2005; 49: 791\u20133.","DOI":"10.1128\/AAC.49.2.791-793.2005"},{"key":"key\n\t\t\t\t20171012225126_B464A","doi-asserted-by":"crossref","unstructured":"McAleese F, Peterson P, Ruzin A et al. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Stophylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother2005; 49: 1865\u201371.","DOI":"10.1128\/AAC.49.5.1865-1871.2005"},{"key":"key\n\t\t\t\t20171012225126_B465","doi-asserted-by":"crossref","unstructured":"Li X, Zolli-Juran M, Cechetto JD et al. Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chem Biol2004; 11: 1423\u201330.","DOI":"10.1016\/j.chembiol.2004.08.014"},{"key":"key\n\t\t\t\t20171012225126_B466","doi-asserted-by":"crossref","unstructured":"Bozja J, Yi K, Shafer WM et al. Porphyrin-based compounds exert antibacterial action against the sexually transmitted pathogens Neisseria gonorrhoeae and Haemophilus ducreyi. Int J Antimicrob Agents2004; 24: 578\u201384.","DOI":"10.1016\/j.ijantimicag.2004.06.008"},{"key":"key\n\t\t\t\t20171012225126_B467","unstructured":"Poole K. Overcoming multidrug resistance in Gram-negative bacteria. Curr Opin Invest Drugs2003; 4: 139."},{"key":"key\n\t\t\t\t20171012225126_B468","unstructured":"Kaatz GW. Bacterial efflux pump inhibition. Curr Opin Invest Drugs2005; 6: 191\u20138."},{"key":"key\n\t\t\t\t20171012225126_B469","doi-asserted-by":"crossref","unstructured":"Mullin S, Mani N, Grossman TH. Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853). Antimicrob Agents Chemother2004; 48: 4171\u20136.","DOI":"10.1128\/AAC.48.11.4171-4176.2004"},{"key":"key\n\t\t\t\t20171012225126_B470","doi-asserted-by":"crossref","unstructured":"Stermitz FR, Cashman KK, Halligan KM et al. Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors. Bioorg Med Chem Lett2003; 13: 1915\u20138.","DOI":"10.1016\/S0960-894X(03)00316-0"},{"key":"key\n\t\t\t\t20171012225126_B471","doi-asserted-by":"crossref","unstructured":"Guz NR, Stermitz FR, Johnson JB et al. Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure\u2013activity relationships. J Med Chem2001; 44: 261\u20138.","DOI":"10.1021\/jm0004190"},{"key":"key\n\t\t\t\t20171012225126_B472","doi-asserted-by":"crossref","unstructured":"Stermitz FR, Beeson TD, Mueller PJ et al. Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu stricto) species. Biochem Syst Ecol2001; 29: 793\u20138.","DOI":"10.1016\/S0305-1978(01)00025-4"},{"key":"key\n\t\t\t\t20171012225126_B473","doi-asserted-by":"crossref","unstructured":"Gibbons S, Oluwatuyi M, Kaatz GW. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother2003; 51: 13\u20137.","DOI":"10.1093\/jac\/dkg044"},{"key":"key\n\t\t\t\t20171012225126_B474","doi-asserted-by":"crossref","unstructured":"Kaatz GW, Moudgal VV, Seo SM et al. Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Int J Antimicrob Agents2003; 22: 254\u201361.","DOI":"10.1016\/S0924-8579(03)00220-6"},{"key":"key\n\t\t\t\t20171012225126_B475","doi-asserted-by":"crossref","unstructured":"Belofsky G, Percivill D, Lewis K et al. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod2004; 67: 481\u20134.","DOI":"10.1021\/np030409c"},{"key":"key\n\t\t\t\t20171012225126_B476","doi-asserted-by":"crossref","unstructured":"Gibbons S, Moser E, Kaatz GW. Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med2004; 70: 1240\u20132.","DOI":"10.1055\/s-2004-835860"},{"key":"key\n\t\t\t\t20171012225126_B477","doi-asserted-by":"crossref","unstructured":"Chopra I. New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors. Drug Resist Updat2002; 5: 119.","DOI":"10.1016\/S1368-7646(02)00051-1"},{"key":"key\n\t\t\t\t20171012225126_B478","doi-asserted-by":"crossref","unstructured":"Gibbons S, Oluwatuyi M, Veitch NC et al. Bacterial resistance modifying agents from Lycopus europaeus. Phytochemistry2003; 62: 83\u20137.","DOI":"10.1016\/S0031-9422(02)00446-6"},{"key":"key\n\t\t\t\t20171012225126_B478A","doi-asserted-by":"crossref","unstructured":"Fujita M, Shiota S, Kuroda T et al. Remarkable synergies between baicalein and tetracycline, and baicalein and \u03b2-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol2005; 49: 391\u20136.","DOI":"10.1111\/j.1348-0421.2005.tb03732.x"},{"key":"key\n\t\t\t\t20171012225126_B479","doi-asserted-by":"crossref","unstructured":"Oluwatuyi M, Kaatz GW, Gibbons S. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry2004; 65: 3249\u201354.","DOI":"10.1016\/j.phytochem.2004.10.009"},{"key":"key\n\t\t\t\t20171012225126_B480","doi-asserted-by":"crossref","unstructured":"Payot S, Avrain L, Magras C et al. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int J Antimicrob Agents2004; 23: 468\u201372.","DOI":"10.1016\/j.ijantimicag.2003.12.008"},{"key":"key\n\t\t\t\t20171012225126_B481","unstructured":"Lomovskaya O, Watkins W. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol2001; 3: 225\u201336."},{"key":"key\n\t\t\t\t20171012225126_B482","doi-asserted-by":"crossref","unstructured":"Saenz Y, Ruiz J, Zarazaga M et al. Effect of the efflux pump inhibitor Phe-Arg-\u03b2-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother2004; 53: 544\u20135.","DOI":"10.1093\/jac\/dkh117"},{"key":"key\n\t\t\t\t20171012225126_B483","doi-asserted-by":"crossref","unstructured":"Sanchez P, Le U, Martinez JL. The efflux pump inhibitor Phe-Arg-\u03b2-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump. J Antimicrob Chemother2003; 51: 1042\u20135.","DOI":"10.1093\/jac\/dkg181"},{"key":"key\n\t\t\t\t20171012225126_B484","doi-asserted-by":"crossref","unstructured":"Nakayama K, Kuru N, Ohtsuka M et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety. Bioorg Med Chem Lett2004; 14: 2493\u20137.","DOI":"10.1016\/j.bmcl.2004.03.007"},{"key":"key\n\t\t\t\t20171012225126_B485","doi-asserted-by":"crossref","unstructured":"Renau TE, Leger R, Filonova L et al. Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett2003; 13: 2755\u20138.","DOI":"10.1016\/S0960-894X(03)00556-0"},{"key":"key\n\t\t\t\t20171012225126_B486","doi-asserted-by":"crossref","unstructured":"Nakayama K, Kawato H, Watanabe J et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model. Bioorg Med Chem Lett2004; 14: 475\u20139.","DOI":"10.1016\/j.bmcl.2003.10.060"},{"key":"key\n\t\t\t\t20171012225126_B487","doi-asserted-by":"crossref","unstructured":"Nakayama K, Ishida Y, Ohtsuka M et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds. Bioorg Med Chem Lett2003; 13: 4205\u20138.","DOI":"10.1016\/j.bmcl.2003.07.027"},{"key":"key\n\t\t\t\t20171012225126_B488","doi-asserted-by":"crossref","unstructured":"Nakayama K, Ishida Y, Ohtsuka M et al. MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization. Bioorg Med Chem Lett2003; 13: 4201\u20134.","DOI":"10.1016\/j.bmcl.2003.07.024"},{"key":"key\n\t\t\t\t20171012225126_B489","doi-asserted-by":"crossref","unstructured":"Watkins WJ, Landaverry Y, Leger R et al. The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors. Bioorg Med Chem Lett2003; 13: 4241\u20134.","DOI":"10.1016\/j.bmcl.2003.07.030"},{"key":"key\n\t\t\t\t20171012225126_B490","doi-asserted-by":"crossref","unstructured":"Renau TE, Leger R, Yen R et al. Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett2002; 12: 763\u20136.","DOI":"10.1016\/S0960-894X(02)00006-9"},{"key":"key\n\t\t\t\t20171012225126_B491","doi-asserted-by":"crossref","unstructured":"Bohnert JA, Kern WV. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother2005; 49: 849\u201352.","DOI":"10.1128\/AAC.49.2.849-852.2005"},{"key":"key\n\t\t\t\t20171012225126_B492","doi-asserted-by":"crossref","unstructured":"Gallo S, Chevalier J, Mahamoud A et al. 4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain. Int J Antimicrob Agents2003; 22: 270\u20133.","DOI":"10.1016\/S0924-8579(03)00215-2"},{"key":"key\n\t\t\t\t20171012225126_B493","doi-asserted-by":"crossref","unstructured":"Mallea M, Mahamoud A, Chevalier J et al. Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J2003; 376: 801\u20135.","DOI":"10.1042\/bj20030963"},{"key":"key\n\t\t\t\t20171012225126_B494","doi-asserted-by":"crossref","unstructured":"Chevalier J, Atifi S, Eyraud A et al. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. J Med Chem2001; 44: 4023\u20136.","DOI":"10.1021\/jm010911z"},{"key":"key\n\t\t\t\t20171012225126_B495","doi-asserted-by":"crossref","unstructured":"Chevalier J, Bredin J, Mahamoud A et al. Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains. Antimicrob Agents Chemother2004; 48: 1043\u20136.","DOI":"10.1128\/AAC.48.3.1043-1046.2004"},{"key":"key\n\t\t\t\t20171012225126_B496","doi-asserted-by":"crossref","unstructured":"Poole K. Uninhibited antibiotic target discovery via chemical genetics. Nat Biotechnol2004; 22: 1528\u20139.","DOI":"10.1038\/nbt1204-1528"},{"key":"key\n\t\t\t\t20171012225126_B497","doi-asserted-by":"crossref","unstructured":"Tegos G, Stermitz FR, Lomovskaya O et al. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother2002; 46: 3133\u201341.","DOI":"10.1128\/AAC.46.10.3133-3141.2002"},{"key":"key\n\t\t\t\t20171012225126_B498","doi-asserted-by":"crossref","unstructured":"Chami M, Steinfels E, Orelle C et al. Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis. J Mol Biol2002; 315: 1075\u201385.","DOI":"10.1006\/jmbi.2001.5309"},{"key":"key\n\t\t\t\t20171012225126_B499","doi-asserted-by":"crossref","unstructured":"Ecker GF, Pleban K, Kopp S et al. A three-dimensional model for the substrate binding domain of the multidrug ATP binding cassette transporter LmrA. Mol Pharmacol2004; 66: 1169\u201379.","DOI":"10.1124\/mol.104.001420"},{"key":"key\n\t\t\t\t20171012225126_B500","doi-asserted-by":"crossref","unstructured":"Pleban K, Macchiarulo A, Costantino G et al. Homology model of the multidrug transporter LmrA from Lactococcus lactis. Bioorg Med Chem Lett2004; 14: 5823\u20136.","DOI":"10.1016\/j.bmcl.2004.09.040"},{"key":"key\n\t\t\t\t20171012225126_B501","doi-asserted-by":"crossref","unstructured":"Ubarretxena-Belandia I, Tate CG. New insights into the structure and oligomeric state of the bacterial multidrug transporter EmrE: an unusual asymmetric homo-dimer. FEBS Lett2004; 564: 234\u20138.","DOI":"10.1016\/S0014-5793(04)00228-5"},{"key":"key\n\t\t\t\t20171012225126_B502","doi-asserted-by":"crossref","unstructured":"Ma C, Chang G. Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli. Proc Natl Acad Sci USA2004; 101: 2852\u20137.","DOI":"10.1073\/pnas.0400137101"},{"key":"key\n\t\t\t\t20171012225126_B503","doi-asserted-by":"crossref","unstructured":"Eswaran J, Koronakis E, Higgins MK et al. Three's company: component structures bring a closer view of tripartite drug efflux pumps. Curr Opin Struct Biol2004; 14: 741\u20137.","DOI":"10.1016\/j.sbi.2004.10.003"},{"key":"key\n\t\t\t\t20171012225126_B504","doi-asserted-by":"crossref","unstructured":"Murakami S, Yamaguchi A. Multidrug-exporting secondary transporters. Curr Opin Struct Biol2003; 13: 443\u201352.","DOI":"10.1016\/S0959-440X(03)00109-X"},{"key":"key\n\t\t\t\t20171012225126_B505","doi-asserted-by":"crossref","unstructured":"Akama H, Kanemaki M, Yoshimura M et al. Crystal structure of the drug-discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end. J Biol Chem2004; 17: 52816\u20139.","DOI":"10.1074\/jbc.C400445200"},{"key":"key\n\t\t\t\t20171012225126_B506","doi-asserted-by":"crossref","unstructured":"Higgins MK, Eswaran J, Edwards P et al. Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC. J Mol Biol2004; 342: 697\u2013702.","DOI":"10.1016\/j.jmb.2004.07.088"},{"key":"key\n\t\t\t\t20171012225126_B507","doi-asserted-by":"crossref","unstructured":"Fernandez-Recio J, Walas F, Federici L et al. A model of a transmembrane drug-efflux pump from Gram-negative bacteria. FEBS Lett2004; 578: 5\u20139.","DOI":"10.1016\/j.febslet.2004.10.097"},{"key":"key\n\t\t\t\t20171012225126_B508","doi-asserted-by":"crossref","unstructured":"Pos KM, Schiefner A, Seeger MA et al. Crystallographic analysis of AcrB. FEBS Lett2004; 564: 333\u20139.","DOI":"10.1016\/S0014-5793(04)00272-8"},{"key":"key\n\t\t\t\t20171012225126_B509","doi-asserted-by":"crossref","unstructured":"Gerken H, Misra R. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli. Mol Microbiol2004; 54: 620\u201331.","DOI":"10.1111\/j.1365-2958.2004.04301.x"},{"key":"key\n\t\t\t\t20171012225126_B510","doi-asserted-by":"crossref","unstructured":"Husain F, Humbard M, Misra R. Interaction between the TolC and AcrA proteins of a multidrug efflux system of Escherichia coli. J Bacteriol2004; 186: 8533\u20136.","DOI":"10.1128\/JB.186.24.8533-8536.2004"},{"key":"key\n\t\t\t\t20171012225126_B511","doi-asserted-by":"crossref","unstructured":"Elkins CA, Nikaido H. Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump. J Bacteriol2003; 185: 5349\u201356.","DOI":"10.1128\/JB.185.18.5349-5356.2003"},{"key":"key\n\t\t\t\t20171012225126_B512","doi-asserted-by":"crossref","unstructured":"Touze T, Eswaran J, Bokma E et al. Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system. Mol Microbiol2004; 53: 697\u2013706.","DOI":"10.1111\/j.1365-2958.2004.04158.x"},{"key":"key\n\t\t\t\t20171012225126_B513","doi-asserted-by":"crossref","unstructured":"Tikhonova EB, Zgurskaya HI. AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J Biol Chem2004; 279: 32116\u201324.","DOI":"10.1074\/jbc.M402230200"},{"key":"key\n\t\t\t\t20171012225126_B514","doi-asserted-by":"crossref","unstructured":"Nehme D, Li XZ, Elliot R et al. Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB. J Bacteriol2004; 186: 2973\u201383.","DOI":"10.1128\/JB.186.10.2973-2983.2004"},{"key":"key\n\t\t\t\t20171012225126_B515","doi-asserted-by":"crossref","unstructured":"Mokhonov VV, Mokhonova EI, Akama H et al. Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa. Biochem Biophys Res Commun2004; 322: 483\u20139.","DOI":"10.1016\/j.bbrc.2004.07.140"},{"key":"key\n\t\t\t\t20171012225126_B516","doi-asserted-by":"crossref","unstructured":"Adler J, Bibi E. Determinants of substrate recognition by the Escherichia coli multidrug transporter MdfA identified on both sides of the membrane. J Biol Chem2004; 279: 8957\u201365.","DOI":"10.1074\/jbc.M313422200"},{"key":"key\n\t\t\t\t20171012225126_B517","doi-asserted-by":"crossref","unstructured":"Adler J, Lewinson O, Bibi E. Role of a conserved membrane-embedded acidic residue in the multidrug transporter MdfA. Biochemistry2004; 43: 518\u201325.","DOI":"10.1021\/bi035485t"},{"key":"key\n\t\t\t\t20171012225126_B518","doi-asserted-by":"crossref","unstructured":"Adler J, Bibi E. Promiscuity in the geometry of electrostatic interactions between the Escherichia coli multidrug resistance transporter MdfA and cationic substrates. J Biol Chem2005; 280: 2721\u20139.","DOI":"10.1074\/jbc.M412332200"},{"key":"key\n\t\t\t\t20171012225126_B519","doi-asserted-by":"crossref","unstructured":"Yu EW, Aires JR, Nikaido H. AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J Bacteriol2003; 185: 5657\u201364.","DOI":"10.1128\/JB.185.19.5657-5664.2003"},{"key":"key\n\t\t\t\t20171012225126_B520","doi-asserted-by":"crossref","unstructured":"McKeegan KS, Borges-Walmsley MI, Walmsley AR. Structural understanding of efflux-mediated drug resistance: potential routes to efflux inhibition. Curr Opin Pharmacol2004; 4: 479\u201386.","DOI":"10.1016\/j.coph.2004.07.002"},{"key":"key\n\t\t\t\t20171012225126_B521","doi-asserted-by":"crossref","unstructured":"Kobayashi N, Nishino K, Yamaguchi A. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol2001; 183: 5639\u201344.","DOI":"10.1128\/JB.183.19.5639-5644.2001"},{"key":"key\n\t\t\t\t20171012225126_B522","doi-asserted-by":"crossref","unstructured":"Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Lett1996; 19: 1\u201324.","DOI":"10.1111\/j.1574-6976.1996.tb00251.x"},{"key":"key\n\t\t\t\t20171012225126_B523","doi-asserted-by":"crossref","unstructured":"Rosenberg EY, Ma D, Nikaido H. AcrD of Escherichia coli is an aminoglycoside efflux pump. J Bacteriol2000; 182: 1754\u20136.","DOI":"10.1128\/JB.182.6.1754-1756.2000"},{"key":"key\n\t\t\t\t20171012225126_B524","doi-asserted-by":"crossref","unstructured":"Moore RA, DeShazer D, Reckseidler S et al. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother1999; 43: 465\u201370.","DOI":"10.1128\/AAC.43.3.465"},{"key":"key\n\t\t\t\t20171012225126_B525","doi-asserted-by":"crossref","unstructured":"Yoshida H, Bogaki M, Nakamura S et al. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol1990; 172: 6942\u20139.","DOI":"10.1128\/jb.172.12.6942-6949.1990"},{"key":"key\n\t\t\t\t20171012225126_B526","doi-asserted-by":"crossref","unstructured":"Gill MJ, Brenwald NP, Wise R. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother1999; 43: 187\u20139.","DOI":"10.1128\/AAC.43.1.187"},{"key":"key\n\t\t\t\t20171012225126_B527","doi-asserted-by":"crossref","unstructured":"Price LB, Vogler A, Pearson T et al. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother2003; 47: 2362\u20135.","DOI":"10.1128\/AAC.47.7.2362-2365.2003"},{"key":"key\n\t\t\t\t20171012225126_B528","doi-asserted-by":"crossref","unstructured":"Ohki R, Murata M. bmr3, a third multidrug transporter gene of Bacillus subtilis. J Bacteriol1997; 179: 1423\u20137.","DOI":"10.1128\/jb.179.4.1423-1427.1997"},{"key":"key\n\t\t\t\t20171012225126_B529","doi-asserted-by":"crossref","unstructured":"Liu J, Takiff HG, Nikaido H. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. J Bacteriol1996; 178: 3791\u20135.","DOI":"10.1128\/jb.178.13.3791-3795.1996"},{"key":"key\n\t\t\t\t20171012225126_B530","doi-asserted-by":"crossref","unstructured":"Pradel E, Pages JM. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents Chemother2002; 46: 2640\u20133.","DOI":"10.1128\/AAC.46.8.2640-2643.2002"},{"key":"key\n\t\t\t\t20171012225126_B531","doi-asserted-by":"crossref","unstructured":"Schneiders T, Amyes SG, Levy SB. Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother2003; 47: 2831\u20137.","DOI":"10.1128\/AAC.47.9.2831-2837.2003"},{"key":"key\n\t\t\t\t20171012225126_B532","doi-asserted-by":"crossref","unstructured":"Baucheron S, Imberechts H, Chaslus-Dancla E et al. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb Drug Resist2002; 8: 281\u20139.","DOI":"10.1089\/10766290260469543"},{"key":"key\n\t\t\t\t20171012225126_B533","doi-asserted-by":"crossref","unstructured":"Alonso A, Martinez JL. Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother2001; 45: 1879\u201381.","DOI":"10.1128\/AAC.45.6.1879-1881.2001"},{"key":"key\n\t\t\t\t20171012225126_B534","doi-asserted-by":"crossref","unstructured":"Valdezate S, Vindel A, Echeita A et al. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother2002; 46: 665\u201371.","DOI":"10.1128\/AAC.46.3.665-671.2002"},{"key":"key\n\t\t\t\t20171012225126_B535","doi-asserted-by":"crossref","unstructured":"Luo N, Sahin O, Lin J et al. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother2003; 47: 390\u20134.","DOI":"10.1128\/AAC.47.1.390-394.2003"},{"key":"key\n\t\t\t\t20171012225126_B535A","doi-asserted-by":"crossref","unstructured":"Kumar A, Worobec EA. Cloning sequencing and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob Agents Chemother2005; 49: 1495\u20131501.","DOI":"10.1128\/AAC.49.4.1495-1501.2005"},{"key":"key\n\t\t\t\t20171012225126_B536","doi-asserted-by":"crossref","unstructured":"Tavio M, Vila J, Ruiz J et al. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition. J Antimicrob Chemother2000; 45: 521\u20134.","DOI":"10.1093\/jac\/45.4.521"},{"key":"key\n\t\t\t\t20171012225126_B537","doi-asserted-by":"crossref","unstructured":"Navia MM, Ruiz J, Ribera A et al. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. J Antimicrob Chemother 1999; 44: 743\u20138.","DOI":"10.1093\/jac\/44.6.743"},{"key":"key\n\t\t\t\t20171012225126_B538","doi-asserted-by":"crossref","unstructured":"Ishii H, Sato K, Hoshino K et al. Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus vulgaris. J Antimicrob Chemother1991; 28: 827\u201336.","DOI":"10.1093\/jac\/28.6.827"},{"key":"key\n\t\t\t\t20171012225126_B539","doi-asserted-by":"crossref","unstructured":"Oh H, Edlund C. Mechanism of quinolone resistance in anaerobic bacteria. Clin Microbiol Infect2003; 9: 512\u20137.","DOI":"10.1046\/j.1469-0691.2003.00725.x"},{"key":"key\n\t\t\t\t20171012225126_B540","doi-asserted-by":"crossref","unstructured":"Miyamae S, Ueda O, Yoshimura F et al. A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob Agents Chemother2001; 45: 3341\u20136.","DOI":"10.1128\/AAC.45.12.3341-3346.2001"},{"key":"key\n\t\t\t\t20171012225126_B541","doi-asserted-by":"crossref","unstructured":"Burse A, Weingart H, Ullrich MS. NorM, an Erwinia amylovora multidrug efflux pump involved in in vitro competition with other epiphytic bacteria. Appl Environ Microbiol2004; 70: 693\u2013703.","DOI":"10.1128\/AEM.70.2.693-703.2004"},{"key":"key\n\t\t\t\t20171012225126_B542","doi-asserted-by":"crossref","unstructured":"Morita Y, Kodama K, Shiota S et al. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob Agents Chemother1998; 42: 1778\u201382.","DOI":"10.1128\/AAC.42.7.1778"},{"key":"key\n\t\t\t\t20171012225126_B543","doi-asserted-by":"crossref","unstructured":"Rouquette-Loughlin C, Dunham SA, Kuhn M et al. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J Bacteriol2003; 185: 1101\u20136.","DOI":"10.1128\/JB.185.3.1101-1106.2003"},{"key":"key\n\t\t\t\t20171012225126_B544","doi-asserted-by":"crossref","unstructured":"Xu XJ, Su XZ, Morita Y et al. Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenzae Rd. Microbiol Immunol2003; 47: 937\u201343.","DOI":"10.1111\/j.1348-0421.2003.tb03467.x"},{"key":"key\n\t\t\t\t20171012225126_B545","doi-asserted-by":"crossref","unstructured":"He GX, Kuroda T, Mima T et al. An H+-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J Bacteriol2004; 186: 262\u20135.","DOI":"10.1128\/JB.186.1.262-265.2004"},{"key":"key\n\t\t\t\t20171012225126_B546","doi-asserted-by":"crossref","unstructured":"Dridi L, Tankovic J, Petit JC. CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family. Microb Drug Resist2004; 10: 191\u20136.","DOI":"10.1089\/mdr.2004.10.191"},{"key":"key\n\t\t\t\t20171012225126_B547","unstructured":"Brown MH, Skurray RA. Staphylococcal multidrug efflux protein QacA. J Mol Microbiol Biotechnol2001; 3: 163\u201370."},{"key":"key\n\t\t\t\t20171012225126_B548","doi-asserted-by":"crossref","unstructured":"McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev1999; 12: 147\u201379.","DOI":"10.1128\/CMR.12.1.147"},{"key":"key\n\t\t\t\t20171012225126_B549","doi-asserted-by":"crossref","unstructured":"Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol Rev1996; 60: 575\u2013608.","DOI":"10.1128\/MMBR.60.4.575-608.1996"},{"key":"key\n\t\t\t\t20171012225126_B550","doi-asserted-by":"crossref","unstructured":"Littlejohn TG, Paulsen IT, Gillespie MT et al. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol Lett1992; 74: 259\u201365.","DOI":"10.1111\/j.1574-6968.1992.tb05376.x"},{"key":"key\n\t\t\t\t20171012225126_B551","unstructured":"Sasatsu M, Shirai Y, Hase M et al. The origin of the antiseptic-resistance gene ebr in Staphylococcus aureus. Microbios1995; 84: 161\u20139."},{"key":"key\n\t\t\t\t20171012225126_B552","doi-asserted-by":"crossref","unstructured":"Heir E, Sundheim G, Holck AL. The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry. J Appl Microbiol1999; 86: 378\u201388.","DOI":"10.1046\/j.1365-2672.1999.00672.x"},{"key":"key\n\t\t\t\t20171012225126_B553","doi-asserted-by":"crossref","unstructured":"Heir E, Sundheim G, Holck AL. The Staphylococcus aureus qacH gene product: a new member of the SMR family encoding multidrug resistance. FEMS Microbiol Lett1998; 163: 49\u201356.","DOI":"10.1111\/j.1574-6968.1998.tb13025.x"},{"key":"key\n\t\t\t\t20171012225126_B554","doi-asserted-by":"crossref","unstructured":"Paulsen IT, Littlejohn TG, Radstrom P et al. The 3\u2032 conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob Agents Chemother1993; 37: 761\u20138.","DOI":"10.1128\/AAC.37.4.761"},{"key":"key\n\t\t\t\t20171012225126_B555","doi-asserted-by":"crossref","unstructured":"Kazama H, Hamashima H, Sasatsu M et al. Distribution of the antiseptic-resistance genes qacE and qacE\u03941 in gram-negative bacteria. FEMS Microbiol Lett1998; 159: 173\u20138.","DOI":"10.1016\/S0378-1097(97)00563-6"},{"key":"key\n\t\t\t\t20171012225126_B556","doi-asserted-by":"crossref","unstructured":"Kazama H, Hamashima H, Sasatsu M et al. Characterization of the antiseptic-resistance gene qacE\u03941 isolated from clinical and environmental isolates of Vibrio parahaemolyticus and Vibrio cholerae non-O1. FEMS Microbiol Lett1999; 174: 379\u201384.","DOI":"10.1016\/S0378-1097(99)00167-6"},{"key":"key\n\t\t\t\t20171012225126_B557","doi-asserted-by":"crossref","unstructured":"Daly M, Fanning S. Integron analysis and genetic mapping of antimicrobial resistance genes in Salmonella enterica serotype Typhimurium. Methods Mol Biol2004; 268: 15\u201332.","DOI":"10.1385\/1-59259-766-1:015"},{"key":"key\n\t\t\t\t20171012225126_B558","doi-asserted-by":"crossref","unstructured":"Bass L, Liebert CA, Lee MD et al. Incidence and characterization of integrons, genetic elements mediating multiple-drug resistance, in avian Escherichia coli. Antimicrob Agents Chemother1999; 43: 2925\u20139.","DOI":"10.1128\/AAC.43.12.2925"},{"key":"key\n\t\t\t\t20171012225126_B559","doi-asserted-by":"crossref","unstructured":"Barlow RS, Pemberton JM, Desmarchelier PM et al. Isolation and characterization of integron-containing bacteria without antibiotic selection. Antimicrob Agents Chemother2004; 48: 838\u201342.","DOI":"10.1128\/AAC.48.3.838-842.2004"},{"key":"key\n\t\t\t\t20171012225126_B560","doi-asserted-by":"crossref","unstructured":"Ploy MC, Courvalin P, Lambert T. Characterization of In40 of Enterobacter aerogenes BM2688, a class 1 integron with two new gene cassettes, cmlA2 and qacF. Antimicrob Agents Chemother1998; 42: 2557\u201363.","DOI":"10.1128\/AAC.42.10.2557"},{"key":"key\n\t\t\t\t20171012225126_B561","doi-asserted-by":"crossref","unstructured":"Plante I, Centron D, Roy PH. Direct sequencing and PCR mapping of integrons reveals multiple class 1 integrons in the multiresistant strain Enterobacter cloacae SCH88040794. FEMS Microbiol Lett2003; 221: 59\u201362.","DOI":"10.1016\/S0378-1097(03)00163-0"},{"key":"key\n\t\t\t\t20171012225126_B562","doi-asserted-by":"crossref","unstructured":"Laraki N, Galleni M, Thamm I et al. Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob Agents Chemother1999; 43: 890\u2013901.","DOI":"10.1128\/AAC.43.4.890"},{"key":"key\n\t\t\t\t20171012225126_B563","doi-asserted-by":"crossref","unstructured":"L'Abee-Lund TM, Sorum H. Class 1 integrons mediate antibiotic resistance in the fish pathogen Aeromonas salmonicida worldwide. Microb Drug Resist2001; 7: 263\u201372.","DOI":"10.1089\/10766290152652819"},{"key":"key\n\t\t\t\t20171012225126_B564","doi-asserted-by":"crossref","unstructured":"Nishino K, Yamaguchi A. EvgA of the two-component signal transduction system modulates production of the YhiUV multidrug transporter in Escherichia coli. J Bacteriol2002; 184: 2319\u201323.","DOI":"10.1128\/JB.184.8.2319-2323.2002"},{"key":"key\n\t\t\t\t20171012225126_B565","doi-asserted-by":"crossref","unstructured":"Edgar R, Bibi E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol1997; 179: 2274\u201380.","DOI":"10.1128\/jb.179.7.2274-2280.1997"},{"key":"key\n\t\t\t\t20171012225126_B566","doi-asserted-by":"crossref","unstructured":"Chung YJ, Saier MH, Jr. Overexpression of the Escherichia coli sugE gene confers resistance to a narrow range of quaternary ammonium compounds. J Bacteriol2002; 184: 2543\u20135.","DOI":"10.1128\/JB.184.9.2543-2545.2002"},{"key":"key\n\t\t\t\t20171012225126_B567","doi-asserted-by":"crossref","unstructured":"Schweizer HP. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob Agents Chemother1998; 42: 394\u20138.","DOI":"10.1128\/AAC.42.2.394"},{"key":"key\n\t\t\t\t20171012225126_B568","doi-asserted-by":"crossref","unstructured":"Gupta A, Matsui K, Lo JF et al. Molecular basis for resistance to silver cations in Salmonella. Nat Med1999; 5: 183\u20138.","DOI":"10.1038\/5545"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/1\/20\/2084917\/dki171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T02:54:26Z","timestamp":1706237666000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/1\/20\/706785\/Effluxmediated-antimicrobial-resistance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,24]]},"references-count":578,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,5,24]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki171","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,7]]},"published":{"date-parts":[[2005,5,24]]}}}